The QualityStocks Daily Thursday, April 6th, 2023

Today's Top 3 Investment Newsletters

QualityStocks(YVR) $0.2622 +87.42%

Schaeffer's(GFAI) $12.7500 +43.42%

MarketClub Analysis(FOA) $1.9300 +30.41%

The QualityStocks Daily Stock List

Liquid Media Group (YVR)

StockMarketWatch, MarketClub Analysis, QualityStocks, Broad Street, TopPennyStockMovers, BUYINS.NET, AwesomeStocks, Fierce Analyst, INO Market Report, InvestorPlace, PremiumPennyPicks, Trades Of The Day, Schaeffer's, Small Cap Firm, StockWireNews, StreetInsider, TradersPro and OTCBB Journal reported earlier on Liquid Media Group (YVR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Liquid Media Group Ltd. (NASDAQ: YVR) (FRA: L7BB) is an entertainment and media firm which is engaged in the development, production and distribution of entertainment contents across various channels and platforms which include gaming, television, film and VR through the firm’s network of shared services.

Liquid Media Group Ltd is based in Vancouver, Canada and was established on August 9, 2018. The firm was known as Leading Brands Inc. before acquiring its current name. The company serves consumers in the United States and Canada and is focused primarily on the business of services-prepackaged software.

Apart from being the only Canadian entertainment studio that listed on NASDAQ, Liquid Media Group Ltd.’s objective is to empower storytellers to create, produce and distribute their work across various platforms and channels.

Liquid Media Group operates through the Video games segment and film segment and has an IP portfolio of over 65 video game titles. The firm produces video games for interactive entertainment hardware platforms and offers video game products mainly for casual game consumers. Additionally, Liquid Media Group distributes third-party TV and film content using its digital platforms and provides broadcasting, animation and VFX production and various streaming services.

In late 2020, Liquid Media Group Ltd announced the expansion of its Slipstream action-adventure sports content through the Unity development platform. This would allow independent filmmakers to achieve widespread distribution across over 20 global platforms like Windows, Xbox, PlayStation, Android, iOS and Mac. This move will increase the firm’s film distribution profile and offer more functionality for the firm’s apps and content while making it easier for filmmakers to gain control of how their work is distributed and monetized, which is bound to be popular among filmmakers and creatives.

Liquid Media Group (YVR), closed Thursday's trading session at $0.2622, up 87.4196%, on 64,976,442 volume. The average volume for the last 3 months is 4.728M and the stock's 52-week low/high is $0.1261/$0.90.

Motorsport Games (MSGM)

QualityStocks, PennyStockProphet, OTCtipReporter, Money Wealth Matters, InsiderTrades, Timothy Sykes, The Online Investor, PennyStockScholar, MarketClub Analysis, MarketBeat, INO Market Report, Broad Street, AwesomeStocks and 247 Market News reported earlier on Motorsport Games (MSGM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Motorsport Games Inc. (NASDAQ: MSGM) is a motorsport network firm that is focused on the development and publishing of multi-platform racing video games.

The firm has its headquarters in Miami, Florida and was incorporated in August 2018. It operates as part of the electronic gaming and multimedia industry, under the communication services sector. The firm has twenty-seven companies in its corporate family and serves consumers around the world.

The company operates through the E-sports and Gaming segments. The E-sports segment is involved in organizing and facilitating e-sports events, competitions and tournaments for licensed racing games, as well as on behalf of other video game publishers and 3rd party video game racing series. On the other hand, the Gaming segment is involved in the development and publishing of interactive racing video games and entertainment services and content. The company operates as a Motorsport Network LLC subsidiary.

The enterprise provides video games for mobile platforms, personal computer platforms and game consoles through a number of digital and retail channels, which include downloadable and full-game content. It also provides motorsport racing series including BTCC (the British Touring Car Championship) and NASCAR. The enterprise is also an e-sports partner of choice for BTCC, Formula E, 24 Hours of Le Mans, NASCAR and the FIA World Rally Cross-Championship. It sells its video game products via various digital and retail channels.

The firm expects to accelerate its growth as well as increase its revenues significantly, which will help create value for its shareholders and bring in more investments into the firm.

Motorsport Games (MSGM), closed Thursday's trading session at $7.74, up 39.9638%, on 4,727,694 volume. The average volume for the last 3 months is 64,012 and the stock's 52-week low/high is $2.01/$49.50.

Upexi Inc. (UPXI)

MarketBeat and QualityStocks reported earlier on Upexi Inc. (UPXI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Upexi Inc. (NASDAQ: UPXI) (FRA: 7TQ) is a multi-faceted brand owner with brands in the health, wellness, pet, beauty and other growing markets.

The firm has its headquarters in Clearwater, Florida and was incorporated in 2018, on September 5th. Prior to its name change in August 2022, the firm was known as Grove Inc. It operates as part of the internet content and information industry, under the communication services sector. The firm primarily serves consumers in the United States.

The company focuses on direct-to-consumer and Amazon brands that are scalable and have anticipated, high industry growth trends. It utilizes its in-house, software-as-a-service (SaaS) programmatic advertising technology to help achieve a lower cost per acquisition and accumulate consumer data for increased cross-selling between its growing portfolio of brands. The company primarily conducts its business operations through its subsidiaries, which include HAVZ LLC, d/b/a/ Steam Wholesale, Cygnet Online LLC (Cygnet) and Interactive Offers LLC (Interactive) and others.

The enterprise operates throughout its locations in the United States, with operations in Florida, California, Nevada and Colorado through its various brands and entities. Tytan is its children's toy brand and maker of magnetic tiles and building blocks. It is also a national distributor for branded consumer products.

The firm, through its Tytan Tiles brand, has seen high demand since its entrance into Walmart stores, almost doubling its initial forecast. It plans to increase brand roll out to thousands of other stores, which will bring in additional revenues into the firm while also extending its consumer reach.

Upexi Inc. (UPXI), closed Thursday's trading session at $3.96, off by 1%, on 64,012 volume. The average volume for the last 3 months is 31,819 and the stock's 52-week low/high is $2.53/$6.08.

Ioneer Ltd (GSCCF)

We reported earlier on Ioneer Ltd (GSCCF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

ioneer Ltd (OTC: GSCCF) (ASX: INR) is a mining exploration and extraction firm that is focused on exploring for and developing mineral properties in North America.

The firm has its headquarters in North Sydney, Australia and was incorporated in 2001. Prior to its name change in November 2018, the firm was known as Global Geoscience Limited. It operates as part of the other industrial metals and mining industry, under the basic materials sector. The firm serves consumers around the world. Geographically, it has a business presence in Australia and North America.

The company is an emerging lithium-boron supplier focused on developing the 100%-owned rhyolite ridge lithium-boron project in the United States. Rhyolite Ridge is a large, shallow lithium-boron deposit located in the southern region of the state of Nevada. This deposit is 25km west of Albemarle’s Silver Peak lithium mine and 330km southeast of the Tesla Gigafactory near Reno. The lithium and boron mineral resource is estimated at 146.5 million metric tons, including an Ore Reserve of 60.0 million metric tons, an increase in Reserves from the Pre-Feasibility Study (PFS) of 280%. The company expects to mine and process 63.8 million metric tons over the 26-year mine life at an average annual rate of 2.5 million metric tons per year.

The enterprise is focused on building a facility to supply lithium within the U.S., having received a $700 million loan from the U.S. Energy department. This aligns with the country’s plan to develop a domestic electric vehicle supply chain, which will, in turn, open the enterprise up to new growth and investment opportunities.

Ioneer Ltd (GSCCF), closed Thursday's trading session at $0.2, off by 3.1008%, on 31,819 volume. The average volume for the last 3 months is 248 and the stock's 52-week low/high is $0.1601/$0.60.

Mitchells & Butlers (MBPFF)

MarketBeat and QualityStocks reported earlier on Mitchells & Butlers (MBPFF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Mitchells & Butlers Plc (OTC: MBPFF) (LON: MAB) (FRA: MABB) is a company focused on owning, operating and managing pubs, restaurants and bars.

The firm has its headquarters in Birmingham, the United Kingdom and was incorporated in 1898. It operates as part of the restaurants industry, under the consumer cyclical sector. The firm primarily serves consumers in the United Kingdom and Germany. Its total estate is comprised of approximately 1,732 sites, of which 1,645 are directly managed.

The company operates under the United Kingdom and Germany geographical segments. Total revenue is split roughly evenly between food sales and beverage sales. It operates through the Alex, Browns, All Bar One, Castle, Ember Inns, Innkeeper's Lodge, Harvester, Miller & Carter, O'Neill's, Nicholson's, Premium Country Pubs, Sizzling Pubs, Toby Carvery, Stonehouse Pizza & Carvery, and Vintage Inns brands and formats. Nearly a quarter of the company’s total sales are generated in London. The company operates through its subsidiaries, which include Mitchells & Butlers Retail Limited, Orchid Pubs & Dining Limited, Ha Ha Bar & Grill Limited, ALEX Gaststatten Gesellschaft mbH & Co KG, Midco 1 Limited, Mitchells & Butlers Finance plc, Mitchells & Butlers Leisure Retail Limited and Mitchells & Butlers Germany GmbH.

The enterprise also engages in the leisure retailing; property leasing, property management, and development; and financing activities, as well as operates as a healthcare trustee. In addition to this, it owns various trademarks.

The company remains committed to better meeting consumer needs by offering quality services while also growing sustainably.

Mitchells & Butlers (MBPFF), closed Thursday's trading session at $2, even for the day. The average volume for the last 3 months is 16,214 and the stock's 52-week low/high is $1.32/$3.10.

Foxconn Interconnect Technology (FITGF)

We reported earlier on Foxconn Interconnect Technology (FITGF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Foxconn Interconnect Technology Co Ltd (OTC: FITGF) (HKG: 6088) (FRA: 0FJ) is an innovative market leader of connectivity technologies within the data center, mobile, computing, and IoT environments.

The firm has its headquarters in New Taipei City, Taiwan and was incorporated in 1974 by Terry Gou. Prior to its name change, the firm was known as Hon Hai Precision Industry Company. It operates as part of the communication equipment industry, under the technology sector. The firm serves consumers in Taiwan, Japan, Hong Kong, the People’s Republic of China, the United States and the United Kingdom, among others.

The company operates as a subsidiary of Foxconn (Far East) Limited. It develops, manufactures and markets electronic and optoelectronic connectors, antennas, acoustic components, cables and modules. Its range of products include backplane connector, high speed connector, input/output (I/O) connectors and power connector; coaxial, external and internal cable assembly; USB cable assembly and wire harness. The company also provides antenna, fiber optic products such as optical transceivers, active optical cables and embedded optical modules; and accessories which include headset, power accessory and speaker system; and LED lighting products. Its products are used in smartphones, broadband and wireless networks, infrastructure of multimedia service operators and telecom operators, terminal products for Internet value-added service providers, infrastructure of enterprise networks and data centers, and automatic manufacturing of precision core components.

The enterprise remains focused on sustainably growing and developing to better meet client needs and generating value for its shareholders.

Foxconn Interconnect Technology (FITGF), closed Thursday's trading session at $0.265, off by 7.9222%, on 16,214 volume. The average volume for the last 3 months is 79,511 and the stock's 52-week low/high is $0.09/$0.3394.

Safe & Green (SGBX)

BUYINS.NET, StockMarketWatch, QualityStocks, MarketClub Analysis, InvestorPlace, PennyStockScholar, Buzz Stocks, HotOTC, OTCtipReporter, 360wallstreet, PennyStockProphet, TradersPro, Profitable Trader Authority, Real Pennies, StockOnion, StreetInsider, TopPennyStockMovers and Penny Pick Finders reported earlier on Safe & Green (SGBX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Safe & Green Holdings Corp (NASDAQ: SGBX) is a design and construction services firm that is focused on designing and modifying code-engineered cargo shipping containers and purpose-built modules for industrial, commercial and residential building construction.

The firm has its headquarters in Miami, Florida and was incorporated in 1993, on December 29th. Prior to its name change, the firm was known as SG Blocks Inc. It operates as part of the metal fabrication industry, under the industrials sector. The firm primarily serves consumers in the United States.

The company operates through the following segments: Construction, Development, Medical, and Corporate and Support. The Construction Services segment includes the manufacturing of unit SG ECHO and other modules projects. The Development segment consists of real property development. The Medical segment consists of joint venture COVID-19 laboratory operations. The Corporate and Support segment is composed of general corporate expenses such as the executive office, corporate finance, accounting, audit, tax, human resources, risk management, information technology, marketing, and legal groups, corporate overhead, and other items not allocated to any of the company's other segments.

The enterprise redesigns, repurposes, and convert heavy-gauge steel cargo shipping containers into SGBlocks, which are green building blocks for construction. It serves developers, architects, builders, and owners. Its products find applications in various markets including single-family and multi-family housing, commercial, entertainment, restaurants, military, and education and student housing.

The firm announced recently that its SG Echo LLC subsidiary had entered into an agreement to provide an additional 90 units for a private, long-standing client. This move will bring in additional revenues for the firm while also opening it up to new investment opportunities.

Safe & Green (SGBX), closed Thursday's trading session at $0.95, off by 4.4362%, on 79,511 volume. The average volume for the last 3 months is 271,837 and the stock's 52-week low/high is $0.76/$2.55.

NextPlat Corp. (NXPL)

QualityStocks and The Stock Dork reported earlier on NextPlat Corp. (NXPL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

NextPlat Corp. (NASDAQ: NXPL), a global e-commerce provider, announced the execution of a binding securities purchase agreement. The agreement was made April 5, 2023, with a strategic, accredited investor. According to the announcement, NXPL agreed to sell 3,428,571 shares of the company's common stock at $0.0001 par value per share. The offering price of the stock was $1.75 per share, or the closing price of the stock on April 4, 2023. The company noted that, in connection with the agreement, the Investor subscribed for, and NextPlat will receive, gross proceeds of approximately $6 million for the stock. The agreement is expected to close on or before April 10, 2023. “This transaction will enhance the company's balance sheet providing additional cash for working capital including supporting the company's newly launched e-Commerce development program, which is designed to assist Florida-based businesses to access international markets in Asia,” the announcement stated.

To view the full press release, visit https://ibn.fm/oYa09

About NextPlat Corp.

NextPlat is a global e-commerce platform company created to capitalize on multiple high-growth sectors and markets for physical and digital assets. The company intends to collaborate with businesses, optimizing the ability to sell their goods online, domestically, and internationally, and enabling customers and partners to optimize their e-commerce presence and revenue. NextPlat currently operates an e-commerce communications services division through its Global Telesat Communications Ltd. and Orbital Satcom Corp. business units, which offer voice, data, tracking and IoT services to customers worldwide through multiple global storefronts. For more information about the company, please visit www.NextPlat.com.

NextPlat Corp. (NXPL), closed Thursday's trading session at $1.98, up 6.4516%, on 271,837 volume. The average volume for the last 3 months is 2.479M and the stock's 52-week low/high is $1.2115/$3.44.

Lordstown Motors Corp. (RIDE)

Green Car Stocks, Schaeffer's, QualityStocks, InvestorPlace, StocksEarning, The Street, StockEarnings, MarketBeat, MarketClub Analysis, Trades Of The Day, Early Bird, Daily Trade Alert, The Online Investor, CNBC Breaking News, Investopedia, GreenCarStocks, Kiplinger Today, StreetInsider, BUYINS.NET, The Stock Dork and Cabot Wealth reported earlier on Lordstown Motors Corp. (RIDE), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Tesla has released its report on vehicle deliveries and production for the first quarter of 2023. Being among the world’s top sellers of electric vehicles, Tesla performed admirably over the last three months, largely meeting the expectations of the market. Tesla had the capability of producing 440,000-plus automobiles and managed to deliver more than 422,000 automobiles during the quarter.

According to reports, Tesla shipped a record-breaking 422,875 automobiles in Q1 2023. Whereas previous key analysts anticipated the company to deliver 421,164 cars, Tesla managed to outperform this level in terms of market performance. Tesla manufactured 440,808 automobiles in quarter 1, which was more than the 432,513 cars predicted by industry analysts.

The majority of deliveries by Tesla during the 2023 first quarter were the Models 3 and Y, with 412,180 of these vehicles reaching consumers by the close of the quarter. On the other hand, only 10,695 of the company’s more premium Model X and Model S vehicles were delivered within that time period. In contrast, out of the 17,147 Model X and Model S premium cars delivered in the previous quarter, this number is down considerably.

The total number of deliveries is up 36% as compared to the 310,048 deliveries reported in Q1 2022. Furthermore, it represents a 4% rise over the 405,278 vehicles that were reportedly delivered in the last quarter of 2022 as well. Tesla therefore outperformed market estimates in terms of both production and sales.

During the company’s last earnings conference, Tesla CEO Elon Musk also stated that the company’s objective for the year 2023 is to produce between 1.8 and 2 million electric vehicles.

With February having only 28 days and the new year holiday break occurring in the quarter, the production of more than 440,000 cars and deliveries of more than 422,000 electric cars is incredibly outstanding. It also foretells favorably for Tesla’s market performance in the upcoming yearly quarters.

According to the company’s release, Tesla will keep moving toward more equitable production volumes for multiple geographic markets, with Model S and X cars going to the Asia-Pacific as well as EMEA (Europe, the Middle East, and Africa) regions. Following the close of business on April 19, 2023, Tesla is set to release its financial figures for Q1 2023.

The success of early pace-setter Tesla should give newer startups such as Lordstown Motors Corp. (NASDAQ: RIDE) all the encouragement they need since the market is theirs to conquer if they can come up with electric vehicle models that appeal to motorists.

Lordstown Motors Corp. (RIDE), closed Thursday's trading session at $0.592, up 1.3005%, on 2,479,499 volume. The average volume for the last 3 months is 1.8M and the stock's 52-week low/high is $0.56/$3.73.

Peabody Energy Corporation (BTU)

MarketClub Analysis, The Street, The Online Investor, Schaeffer's, StreetInsider, InvestorPlace, Daily Wealth, MarketBeat, QualityStocks, SmarTrend Newsletters, The Growth Stock Wire, Money Morning, Daily Markets, Hit and Run Candle Sticks, Barchart, TheStockAdvisors, TheStockAdvisor, StreetAuthority Daily, TopStockAnalysts, Marketbeat.com, BUYINS.NET, TradersPro, Daily Trade Alert, Energy and Capital, Wealth Daily, Zacks, Kiplinger Today, SmallCap Network, SureMoney, WStreet Market Commentary, ProfitableTrading, Wall Street Daily, Forbes, Street Insider, Trading Concepts, The Motley Fool, Investment House, Investing Futures, The Wealth Report, INO.com Market Report, Trades Of The Day, Dividend Opportunities, Wyatt Investment Research, Investors Alley, Top Pros' Top Picks, The Tycoon Report, TradingMarkets, Trade of the Week, Uncommon Wisdom, INO Market Report, Investment U, StrategicTechInvestor, Dynamic Wealth Report, Money and Markets, Cabot Wealth, Inside Investing Daily, Investing Daily, Daily Stocks, FNNO Newsletters, StockEarnings, Wealthpire Inc., Wall Street Elite, Trading Markets, Top Stock Picks, Today's Financial News, TheTradingReport, The Trading Report, StockTwits, SmallCapNetwork, Stockhouse, InvestmentHouse, Stock Tips Network, Stock Gumshoe, Stock Beast, AllPennyStocks, Market Intelligence Center Alert, Market Intelligence Center, Market Authority, InvestorGuide, Investopedia and StockMarketWatch reported earlier on Peabody Energy Corporation (BTU), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A recent report from environmental policy group iFOREST indicated that India will need $900 billion to wean itself off coal. The New-Delhi based group released two reports predicting the amount of money India would need to support its transition from coal and other dirty fuels to clean and renewable energy.

These estimates also accounted for the cost of creating new jobs for individuals who are currently working at centers that use fossil fuels such as coal and oil.

Transitioning from coal and other polluting energy sources is integral to reducing greenhouse gas emissions and combating climate change. However, fossil fuels are so entrenched in modern society that moving from them without proper financial and policy support can have significant economic consequences. Millions of people globally work in industries that are involved with fossil fuels. Proper planning and sufficient investment can help shield these individuals from the economic fallout of transitioning from dirty energy sources such as coal.

However, building new renewable technology will be the most significant investment in the green energy transition. The report estimated that India would spend up to $472 billion by 2050 on clean-energy infrastructure, with the creation of new clean-energy jobs costing $9 billion (10% of the total investment). According to iFOREST, $600 billion of the total investment would be investments in new infrastructure and industries, while the remaining $300 billion would be government support offered to affected communities and workers in the coal industry.

Sandeep Pai from the policy group Center for Strategic and International Studies said a green-energy transition in India would be a massive undertaking impacting up to 20 million energy workers. He noted that such reports are crucial to pushing the green-energy transition in India since it is still in its infancy.

India is responsible for 7% of global emissions and is the largest greenhouse gas emitter in the world after the European Union, China, and the United States. The country relies on coal to generate up to 75% of its electricity and uses coal to supply 55% of its total energy demand.

The country recently increased energy generation at coal plants after the government invoked emergency orders and instructed coal plants to run at full power throughout the summer to prevent outages.

Despite this, India is part of a global movement that plans to eliminate emissions by moving away from dirty fuels and has pledged to reach net zero emissions by 2070. However, transitioning away from coal is easier said than done, and the world is likely to see leading coal producers such as Peabody Energy Corporation (NYSE: BTU) around for a lot longer while countries find workable ways to phase out coal energy from their energy mix.

Peabody Energy Corporation (BTU), closed Thursday's trading session at $25.25, off by 2.472%, on 1,799,738 volume. The average volume for the last 3 months is 377,002 and the stock's 52-week low/high is $17.42/$33.29.

Compass Pathways PLC (CMPS)

InvestorBrandNetwork, QualityStocks, InvestorPlace, MarketBeat, Daily Trade Alert, StreetInsider, Schaeffer's, Trades Of The Day and The Street reported earlier on Compass Pathways PLC (CMPS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A recent study has found that U.S. Special Forces veterans who underwent psychedelic treatment had lower levels of PTSD and alcohol misuse. Military veterans are much more likely to experience mental health conditions such as PTSD and depression, but existing treatments aren’t always effective.

Psychedelics are poised to play a major role in the evolution of the psychiatric industry over the next decade as researchers work to develop safer and more effective treatments. Research into psychedelic drugs including psilocybin, mescaline and MDMA has found that they can alleviate the symptoms of several mental health conditions with minimal side effects.

Hallucinogenics’ ability to treat conditions such as major depressive disorder and post-traumatic stress disorder (PTSD) makes them especially beneficial for treating veterans who tend to have mental health conditions at much higher rates than the general population. A The new study sought to determine how U.S. Special Operations Forces veterans responded to 5-MeO-DMT and ibogaine therapy.

Researchers found a “significant reduction” in alcohol misuse disorder only a month after the veterans started treatment. Furthermore, these effects lasted for six months after the first treatment session. The researchers also determined that the therapy caused a “strong reduction” in PTSD symptoms.

Soldiers who survive wars often come back home with severe psychological scars. In fact, 7 in 100 veterans are estimated to develop PTSD eventually, and 20% of military vets deal with depression. PTSD from taking part in war often involves flashbacks to traumatic experiences, frightening thoughts, bad dreams, emotional numbing and other symptoms. Many veterans turn to alcohol to cope with these effects, leading to high rates of alcohol misuse among military veterans.

Clinical psychologist and postdoctoral scholar at Ohio State University’s Center for Psychedelic Drug Research and Education Stacey Armstrong is one of the study’s authors; she has worked as a trauma psychologist for several years. In her years of practice, she worked with many people, including military vets, who had been “exposed to atrociously traumatic experiences.”

Armstrong said that many patients did not respond positively to traditional treatments, which has increased her interest in the nascent field of psychedelic-assisted therapy. She and her colleagues reviewed data collected in a Mexican clinical treatment program from 45 male Special Forces vets undergoing treatment with 5-MeO-DMT and ibogaine. They noted that the patients reported major reductions in PTSD symptom severity and alcohol drinking levels.  The researchers also noticed a significant cognitive functioning improvement that remained half a year after treatment. They published their findings in the “Military Psychology journal.

As companies within the psychedelic industry such as Compass Pathways PLC (NASDAQ: CMPS) delve further into these hallucinogenic substances, we are likely to learn more about the different ways through which these compounds work.

Compass Pathways PLC (CMPS), closed Thursday's trading session at $10.49, up 4.5862%, on 377,002 volume. The average volume for the last 3 months is 448,894 and the stock's 52-week low/high is $6.54/$21.50.

Canaan Inc. (CAN)

QualityStocks, MarketClub Analysis, Schaeffer's, InvestorPlace, TradersPro, StreetInsider, MarketBeat, Stockhouse, AllPennyStocks, StockEarnings, INO Market Report, BUYINS.NET, InvestorsUnderground, Stock Fortune Teller, Trades Of The Day, StockMarketWatch, StocksEarning, The Online Investor, The Street, TopStockAnalysts and SmarTrend Newsletters reported earlier on Canaan Inc. (CAN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The European Union (EU) is considering the implementation of a cap on anonymous cryptocurrency transactions to combat financial fraud and terrorism funding. The proposed cap is set at $1,083 for transactions where a client cannot be recognized, while the maximum amount for money transfers would be $7,585.

The measures are part of a larger push for improved openness in the banking industry and will be subject to negotiations before being approved at a plenary meeting in April.

The EU’s initiative is a response to the ease with which cryptocurrency transactions can be conducted anonymously, making it difficult to track illegal activities. The new rules aim to enhance transparency and responsibility in the cryptocurrency industry.

The European Authority against Money Laundering (AMLA), established in June 2022, will be responsible for enforcing the new laws. The AMLA has emphasized the need for close coordination between the regulatory regime and national authorities, and has demanded proactive oversight of high-risk financial services and cryptocurrency service providers that operate across multiple member nations.

Lawmakers overwhelmingly adopted the language dealing with unnamed instruments, particularly crypto, with 99 votes in favor, 8 opposing, and 6 abstaining. The EU’s measures are part of a larger effort to increase financial regulation.

Prior to this, the Central Bank of Europe had warned of the dangers of virtual currencies to financial stability and urged an international approach to regulation. The EU’s measures also follow similar efforts by other nations, including China, to strengthen controls on digital currency assets.

The draft proposal stipulates that companies providing services for crypto assets must identify themselves with relevant authorities, perform proper client checks and notify authorities of any unusual activity. The EU also intends to create a new institution to oversee the implementation of these laws in all member nations.

While the plans have received support from the finance industry, others have expressed concerns about the potential impact on confidentiality and the practicality of implementing the new standards. Nevertheless, the EU’s measures are part of an ongoing commitment to combat money fraud and terrorist funding, and the proposed cap on anonymous cryptocurrency transactions represents one phase of this effort.

The proposed laws attempt to align the cryptocurrency industry with conventional financial entities and may promote institutional investors’ use of cryptocurrencies. Several experts caution that these laws may potentially hinder innovation and entice companies away from Europe in favor of nations with more tolerant crypto regulations.

However, the industry and leading actors such as Canaan Inc. (NASDAQ: CAN) need clear regulatory policies that can enable the companies to make long-term plans with the certainty that the rules under which they operate are stable and support their growth.

Canaan Inc. (CAN), closed Thursday's trading session at $2.49, off by 0.796813%, on 448,894 volume. The average volume for the last 3 months is 25,040 and the stock's 52-week low/high is $1.87/$6.24.

The QualityStocks Company Corner

Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF)

The QualityStocks Daily Newsletter would like to spotlight Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF).

Eloro Resources released updates on Iska Iska project at MetalsInvestor Forum held in Toronto on March 3-4, 2023

Iska Iska is a major silver-tin polymetallic porphyry-epithermalcomplex located in southern Bolivia

Drilling revealed significant breccia pipe containing extensivesilver polymetallic mineralization and a high-grade gold-bismuthzone in the underground workings

Eloro recently acquired Mina Casiterita and Mina Hoyada properties,geological mapping, sampling, and geophysical surveys in progress,drilling planned in Q1-2023

Dr. Bill Pearson, Executive Vice President of Exploration for Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) recently revealed promising drilling results from the company’sIska Iska project in Bolivia at the Metals Investor Forum held inToronto on March 3-4, 2023 (https://ibn.fm/1BXUl).

Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) is a publicly traded exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec.

The company has an option to acquire a 99% interest in the highly prospective Iska Iska Property, classified as a silver-tin polymetallic epithermal-porphyry complex, a significant mineral deposit type in the Potosi Department of southern Bolivia. Iska Iska is a road-accessible, royalty-free property.

Eloro also owns an 82% interest in the La Victoria Gold/Silver Project, located in the North-Central Mineral Belt of Peru, some 50 kilometers south of Barrick’s Lagunas Norte Gold Mine and Pan American Silver’s La Arena Gold Mine. La Victoria consists of eight mining concessions and eight mining claims encompassing approximately 89 square kilometers. La Victoria has good infrastructure, with access to road, water and electricity, and is located at an altitude that ranges from 3,150 meters to 4,400 meters above sea level.

The company has a strong management and technical team working diligently to uncover the value of both Iska Iska and La Victoria. Eloro is based in Toronto, Canada.

Projects

Iska Iska – Potosi, Bolivia

Iska Iska is associated with a Miocene possibly collapsed/resurgent caldera, emplaced on Ordovician age rocks with major breccia pipes, dacitic domes and hydrothermal breccias. The property is wholly controlled by the title holder, Empresa Minera Villegas S.R.L. It is located 48 kilometers north of Tupiza city, in the Sud Chichas Province of the Department of Potosi. This is an important mineral deposit type in the prolific South Mineral Belt of Bolivia. Eloro commissioned a NI 43-101 Technical Report on Iska Iska, which was completed by Micon International Limited and is available on Eloro’s website and under its filings on SEDAR.

A fully financed drill program is currently underway on the property, situated near world-class deposits including Silver Sand, San Bartolomé, Pulacayo, San Cristobal, San Vicente, Chorolque, Tasna, Choroma and Siete Suyos. Iska Iska is in the southwest part of the Eastern Cordillera, which hosts a number of major polymetallic mines and mineral deposits. Drilling and continuous channel sampling results have demonstrated some very high metal values, especially silver and tin, within an immense system, where mineralization has been encountered in every drill hole to date. The company believes there is excellent potential for world-class bulk mineable deposits.

La Victoria – Ancash, Peru

The La Victoria project, targeting gold and silver production, is situated near world-class, low-cost gold producers Pan American Silver and Barrick Gold Corporation. Located in Ancash Department, La Victoria sits on the western slopes of the Peruvian Andes. The property is located 12 hours from Lima, with a travel distance of 600 kilometers. The nearest road accessible population centers from La Victoria are Huandoval, Pallasca and Cabana. The project includes four principal mineralized zones in Peru’s prolific North-Central Mineral Belt – San Markito, Victoria, Victoria South and Ccori Orcco – with excellent potential for gold discovery. Operations at La Victoria are planned to proceed with a 2,000-meter diamond drilling program to test targets to outline potential resources at San Markito. Trenching and sampling confirmed high silver values and veins at San Markito in 2020.

Market Outlook

According to industry association The Silver Institute, the outlook for silver demand is exceptionally promising, with global demand forecast to rise to a record high of 1.112 billion ounces in 2022. The increase will be driven by record silver industrial fabrication, which is forecast to improve by 5%, as silver’s use expands primarily in solar energy and electric vehicle (EV) manufacturing. The institute states that government commitments to carbon neutrality have resulted in a rapid expansion of green energy projects, driving record photovoltaic panel installations which are expected to lift silver demand in this segment to an all-time high in 2022.

Rising demand in the electronics industry is also boosting the demand for tin, which is primarily used in solder. The electronics and electrical industries use solders containing 40-70% tin, which provide strong and reliable joints under a variety of environmental conditions. At present, the majority of the assemblers are using patented tin-and-copper-based solders. Mordor Intelligence estimated tin demand at 387 kilotons in 2021 and forecasts demand growth of 2.5% annually through 2027. Over the medium term, surging demand from the EV market and increasing applications in the electrical and electronics industry is expected to drive the market.

Management Team

Thomas G. Larsen is CEO of Eloro. He has more than 40 years of experience in the investment industry, specializing in corporate finance and management of junior resource companies, raising in excess of C$200 million. He previously held the position of President and Chief Executive Officer of Champion Iron Limited. Prior to that, he was President and Chief Executive Officer of Champion Iron Mines Limited.

Dr. Bill Pearson is Executive VP of Exploration for Eloro. He has more than 40 years of direct experience in the exploration and production of minerals worldwide. He played an integral role in the acquisitions of Desert Sun Mining Corp. by Yamana Gold in 2006 and Central Sun Mining by B2 Gold in 2009. He was formerly VP Exploration at Desert Sun Mining and Senior VP at Central Sun Mining.

Miles Nagamatsu, CPA, is CFO at Eloro. He has over 30 years of experience in accounting, management, lending, restructurings and turnarounds. Since 1993, he has acted as a CFO of public and private companies primarily in the mineral exploration and investment management sectors. He holds a Bachelor of Commerce degree from McMaster University.

Osvaldo Arce Burgoa is General Manager at Eloro. He is a geological and mineral processing engineer with 26 years of experience in Bolivia. He is a former President of the Bolivian Geological Society, Main Technical Advisor of the National Mining Corporation (COMIBOL) and has served as exploration manager and chief geologist at various mining and exploration companies. He has authored two books on Bolivian geology and holds a doctorate in mining engineering from Tohoku University in Sendai, Japan.

Eloro Resources Ltd. (OTCQX: ELRRF), closed Thursday's trading session at $2.7001, up 0.75%, on 25,040 volume. The average volume for the last 3 months is 58,855 and the stock's 52-week low/high is $2.09/$4.05.

Recent News

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF)

The QualityStocks Daily Newsletter would like to spotlight Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF).

Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) today announced the selection of an 80,800 square-foot brownfieldfacility within the England Airpark in Alexandria, Louisiana, asthe location for its planned Louisiana Strategic Metals Complex(“LSMC”) rare earth element (“REE”) separation and oxide productionfacility. “Ucore has executed a very focused plan to establish itsfirst rare earth processing plant within an existing brownfieldfacility,” said Pat Ryan, P.Eng., Ucore chairman and CEO. “Thisplan accelerated once Ucore narrowed its U.S. Gulf Coast search toLouisiana and worked through many excellent potential sitesthroughout the state. Critical success markers included streamlinedlogistics, access to chemicals and reagents, attractive energycosts, labor pool robustness, room for ramp-up and productionexpansion, and community support, including technical educationinfrastructure. Several communities around the state were veryseriously considered, yet England Airpark and the community ofAlexandria presented local partnership and expansion opportunitiesto ensure Ucore achieves and perhaps exceeds its originalobjectives.”

To view the full press release, visit https://ibn.fm/bebgU

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) is engaged in Rare Earth Element (REE) resource development and in commercializing its critical metals separation technology, RapidSX™, for the mining and metals extraction industry. The company is guided by principles of environmental, social and corporate governance (ESG) with a focus on disrupting China’s current dominance of the U.S. REE supply chain.

Ucore’s vision is to become a leading advanced technology company providing best-in-class metal separation products and services to the mining and mineral extraction industry. It plans to aid in the development, through strategic partnerships, of a North American REE supply chain controlled by the U.S. and its allies.

The company intends to contribute to this initiative through the near-term development of a heavy and light rare-earth processing facility in Louisiana and subsequent development of Strategic Metals Complexes (SMCs) in Alaska and Canada, as well as through the longer-term development of its 100%-owned Heavy Rare Earth Element (HREE) mineral resource property at Bokan Mountain on Prince of Wales Island, Alaska.

Ucore is headquartered in Halifax, Nova Scotia.

Projects & Technology

RapidSX™ Demonstration Plant

The Kingston, Ontario, RapidSX™ Demonstration Plant commissioning process is underway. Once commissioned, the plant is designed to demonstrate the commercial capabilities of the RapidSX technology platform.

The RapidSX demo plant will show:

  • The techno-economic advantages of the RapidSX technology platform
  • The processing of tens of tons of heavy and light mixed rare earth element concentrates in a simulated production environment
  • The platform’s ability to operate for thousands of semi-continuous run-time hours
  • Production of high-purity NdPr, praseodymium, neodymium, terbium and dysprosium rare earth elements for early OEM product qualification trials

The demo plant is located within Ucore’s 5,000-square-foot RapidSX Commercialization and Demonstration Facility and is run by its laboratory partner, Kingston Process Metallurgy Inc. (“KPM”).

RapidSX™ Technology

Innovation Metals Corp., acquired by the company in 2020, developed the RapidSX separation technology platform with early-stage assistance from the United States Department of Defense, later resulting in the production of commercial-grade, separated rare earth elements at pilot scale.

RapidSX combines the time-proven chemistry of conventional solvent extraction (SX) with a new column-based platform that significantly reduces time to completion and plant footprint, as well as potentially lowering capital and operating costs. SX is the international REE industry’s standard commercial separation technology and is currently used by all REE producers worldwide for bulk commercial separation of both heavy and light REEs.

Utilizing similar chemistry to conventional SX, RapidSX is not a “new” technology, but it represents a significant improvement on the well-established, well-understood, proven conventional SX separation technology preferred by REE producers.

Strategic Metals Complex

Ucore, engineering partner Mech-Chem Associates Inc. and KPM are developing the full-scale engineering for the company’s first Strategic Metals Complex (SMC). The SMC is a planned REE separation and rare earth oxide production plant slated to commence construction in Louisiana in 2023. It is scheduled to initially process 2,000 tons of total rare earth oxides by the end of 2024, increasing to 5,000 tons in 2026.

Bokan-Dotson Ridge REE Deposit

Ucore has invested over C$35 million to establish and validate the Bokan-Dotson Ridge resource in preparation for mine design and permitting. Initial drilling is complete, and a Preliminary Economic Assessment has been issued. Next steps for the project include a feasibility study, detailed mine design and permit acquisition. The project can be “near shovel ready” for construction in less than 30 months after receipt of the next stage of development funding.

Market Opportunity

According to a report by Grand View Research, the global rare earth elements market was valued at $2.8 billion in 2018 and is forecast to reach a value of $5.6 billion by 2025, achieving a CAGR of 10.4% during the period. Market growth is driven by increasing demand for these elements in the manufacturing of magnets and catalysts for the automotive industry. Rising demand for electric vehicles to reduce CO2 emissions is expected to propel the use of permanent magnets in the production of EV batteries.

China is the major producer and consumer of REEs. To maintain self-sufficiency and to meet future demand, China has been raising the export tariffs on rare earth elements shipped to various countries, including the U.S., Japan, India, Brazil and the European Union. This led to the current supply-demand gap in these countries, as they rely on imports from China.

China reduced the exports of REEs by 72% in the second half of 2010 to preserve its reserves of these elements and continues to export REEs at reduced levels, thereby affecting industries such as automotive, oil and gas, and electronics, which require an ample amount of rare earth elements.

Management Team

Pat Ryan, P.Eng., is Chairman and CEO of Ucore Rare Metals. He began as a director with the company when he developed a heightened interest in critical metals. Before joining Ucore, he founded and led a multimillion-dollar automotive OEM design and lean manufacturing company. His understanding of complex supply chains across international markets has led to a prime positioning as the global auto industry transitions to vehicle electrification. He holds a Bachelor of Engineering degree from Dalhousie University.

Peter Manuel is Vice President and CFO of Ucore. Prior to joining the company, he practiced as a Chartered Accountant for more than 17 years, providing consulting services to companies in a range of industries, with a focus on the financial services and resource sectors. He spent 10 years in England and Ireland providing assurance, strategic planning, corporate finance and other consulting services to a portfolio of both public and private entities. He holds a Bachelor of Commerce Degree from Dalhousie University.

Michael Schrider, MEng, P.E., is Vice President and COO of Ucore. He is a multidisciplinary engineer who has been involved in manufacturing, engineering and managing complex structural and mechanical systems projects since 1989. He was the Founder, President and Chief Engineer of Schrider & Associates and Alton Bay Design, both engineering services firms. He holds a bachelor’s degree in naval architecture and marine engineering from the University of New Orleans and a master’s degree in mining, geological and geophysical engineering from the University of Arizona.

Mark MacDonald is Vice President of Investor Relations at Ucore. He has over 25 years of experience implementing award winning business development and marketing programs at regional and national levels. As Vice President of Sales, he was responsible for Mediapro Communication’s growth as AT&T Canada’s leading B2B sales partner. He subsequently became Atlantic Regional Vice President of AT&T Canada Corp. He holds a Bachelor of Commerce degree from Dalhousie University.

Ucore Rare Metals Inc. (UURAF), closed Thursday's trading session at $0.945, up 2.7174%, on 58,855 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $4.05/$.

Recent News

Advanced Container Technologies Inc. (OTC: ACTX)

The QualityStocks Daily Newsletter would like to spotlight Advanced Container Technologies Inc. (OTC: ACTX).

The recent coronavirus pandemic underscored how dangerous viralinfections can be when they get out of hand. The communicablerespiratory disease took nearly 7 million lives, bringing the globe to a standstill as countries shut theirborders to prevent infections. In a recent study, researchers triedto determine whether similar viral infections and autoimmunediseases were connected.Autoimmune conditions occur when an individual’s immune system mistakes healthy tissuefor foreign invaders and begins attacking the body. Although westill don’t know the exact cause of autoimmune diseases, scientistshave spent decades studying the underlying mechanisms involved in the development of autoimmune diseases to develop moreeffective ways of treatment. Roughly 5–8% of the U.S. population is affected by autoimmune conditionsincluding type 1 diabetes, multiple sclerosis (MS) and inflammatorybowel disease (IBD). Scientists posit that the diseases occur dueto a mix of genetic and nongenetic factors such as diet, toxicchemicals and pathogens that increase the risk of autoimmunity.Chronic viral infections seem to be a risk factor in autoimmunity,with the recent COVID-19 pandemic being accompanied by a rise in autoimmune disorder cases in patients diagnosed with the coronavirus. Autoimmune conditionsare taking an increasing toll on economies and communities, and anumber of enterprises, such as Aditxt Inc. (NASDAQ: ADTX), are rising to the challenge by conducting R&D programs aimedat finding ways to reprogram immune systems of individuals with aview to rolling back the malfunctions that trigger autoimmunity.

Advanced Container Technologies Inc. (OTC: ACTX) is in the business of selling and distributing self-contained, automated, indoor “micro-farms” called Grow Pods, along with related equipment and supplies. Additionally, the company designs and sells patented proprietary medical-grade plastic containers, known as the Medtainer®, that store and grind pharmaceuticals, herbs, teas and other solids or liquids.

ACTX is the leading distributor of Grow Pods. With a controlled environment, food and herbs can be grown without pesticides, harmful chemicals or risk of pathogen contamination, and with low energy consumption. Restaurants, grocery stores, non-profits, MSOs and entrepreneurs can use Grow Pods to ensure a fresh supply of ultra-clean produce year-round.

The company entered the Grow Pod business in October 2020 with its acquisition of all shares of Advanced Container Technologies Inc., a California corporation. As of February 28, 2022, ACTX is exploring the acquisition of the assets and the assumption of some or all of the liabilities of GP Solutions Inc., the developer and manufacturer of Grow Pods, for which ACTX is currently the sole U.S. distributor.

Because Grow Pods can be located almost anywhere, produce can be grown closer to the point of consumption and harvested at its peak, providing nutritious fruits and vegetables where needed. Indoor micro-farms, utilizing a practice known as vertical farming, have attracted the attention of governments and universities, which are now promoting vertical farming as a way to combat food insecurity and inequities.

The United States Department of Agriculture (USDA) has stated that vertical farming “is no longer a futuristic concept.” The department is enthusiastic about vertical farming, particularly those utilizing repurposed shipping containers, such as Grow Pods. Arizona State University reports that vertical farming reduces water use by 90 percent compared to conventional farming but produces 10 times the crop yield.

Products

Grow Pods

One of the company’s main business units is focused on selling advanced, self-contained hydroponic containers called Grow Pods. These unique and innovative automated systems are essentially micro-farms that can be placed virtually anywhere and, with their controlled and specially filtered environment, allow cultivation of a wide variety of crops, 365 days a year. The Grow Pod controlled environment offers major advantages for the production of high-value crops. The ability to grow year-round and the ability to cultivate in a smaller footprint using less water and power are some of the primary advantages of the system. Grow Pods offer constant temperature, humidity and airflow control, as well as automated watering and lighting schedules for optimal growth and minimal labor requirements, regardless of crop.

Containers

ACTX meets the needs of the pharmaceutical and medical markets, including the cannabis and hemp industries, with patented packaging systems. The company designs, customizes, brands and sells proprietary medical grade plastic containers that can store pharmaceuticals, herbs, teas and other solids or liquids, with a special built-in feature that can grind solids and shred herbs. The company’s flagship container product is the patented Medtainer®, a child resistant, medical-grade herb container and grinder that is water-tight, air-tight and smell proof. Packaging in the cannabis industry is critical, with numerous stringent regulations about how cannabis products must be packaged and labeled. ACTX also offers custom-branded, compliant vacuum seal bags and other retail container solutions.

Equipment and Supplies

ACTX markets and sells two principal products: Grow Pods, which are specially modified insulated shipping containers manufactured by GP Solutions Inc., in which plants, herbs and spices may be grown hydroponically in a controlled environment, and Medtainers®, which may be used to store pharmaceuticals, herbs, teas and other solids or liquids and can grind solids and shred herbs. The company also markets and sells various products related to Grow Pods and the Medtainer®, as well as providing private labeling and branding services for purchasers of Medtainers® and certain related products.

GP Solutions manufactures and sells other products, such as humidity controllers and LED lighting systems for vertical farming. The company’s specially designed lighting panels are programmed to emit the exact wavelength of light that each crop requires. The system has a daybreak-to-nightfall feature that gives plants the proper chromatic signals to grow rapidly and fruitfully. High efficiency LED light strips supply the crops with a red and blue light spectrum required for photosynthesis in the spectrum that plants need most.

Market Overview

The global vertical farming market is expected to reach $33.02 billion by 2030, according to a new report by Grand View Research. The market is forecast to expand at a CAGR of 25.5 percent from 2022 to 2030, according to Grand View. Escalating production of biopharmaceutical products, including cannabis, is anticipated to drive the market. The building-based segment of the market is expected to register a significant CAGR of 27.8 percent over the projected period. In addition, the climate control segment is expected to see high growth.

The global cannabis packaging market is expected to reach $14.34 billion by 2028, according to analysis by Reports and Data. The analysis forecasts 1,700 percent growth in cannabis users by the end of 2026, with packaging likely observing a whopping 26.42 percent growth in the forecast period. There are significant barriers to entry in the cannabis packaging market, giving an advantage to companies already established in the sector. These barriers include developing a thorough knowledge of the myriad regulations that govern cannabis packaging (which differ in each state), and child-resistance requirements.

Management Team

Douglas P. Heldoorn is the Founder and Chairman of Advanced Container Technologies Inc. He also holds the positions of President, CEO and COO at the company. Mr. Heldoorn has served on the Board of Directors since its inception in 2013. He has also previously held the position of Executive General Manager at Nissan Motor Corp.

Jeffory A. Carlson is CFO and Treasurer of ACTX. Mr. Carlson has also served as the company’s Corporate Controller since 2014.

Advanced Container Technologies Inc. (OTC: ACTX), closed Thursday's trading session at $0.863, up 1.5294%, on 22,463 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.8304/$28.49.

Recent News

India Globalization Capital Inc. (NYSE American: IGC)

The QualityStocks Daily Newsletter would like to spotlight India Globalization Capital Inc. (NYSE American: IGC).

Only hours before the end of the 2023 session, a proposal to make medical marijuana legal in Kentucky wentthrough the state senate on Thursday after ten years of fruitlessattempts. In front of a bipartisan group of lawmakers andsupporters on Friday morning, Governor Andy Beshear enacted thelegislation, putting Kentucky among the states resolving to end theprohibition of medicinal marijuana. The initiative will be activestarting in early 2025. In two of the previous three years, HouseRepresentatives had approved a medicinal marijuana measure, whichwas rejected at the Senate because of insufficient support from theparty’s Republican caucus. The law was introduced on the floor ofthe Senate this year and was successfully passed through that chamber two weeks ago. While Kentucky is celebrating the enactment of a medicalmarijuana law, residents can also take additional comfort from theknowledge that there are companies like India Globalization Capital Inc. (NYSE American: IGC) that are working tirelessly to develop pharmaceutical-grademedicines from a number of cannabis compounds for the treatment ofailments like chronic pain.

India Globalization Capital Inc. (NYSE American: IGC), through subsidiary IGC Pharma, develops, patents, and markets advanced THC-based drug formulations for the treatment of symptoms related to various diseases including but not limited to Alzheimer’s disease, Tourette syndrome, chronic pain, and pet seizures.

IGC’s leading drug candidate, IGC-AD1, has completed Phase 1 of a safety and tolerability trial and entered Phase 2 trials for treating agitation in patients with Alzheimer’s dementia, the first study in humans of a natural tetrahydrocannabinol (THC) compound plus another molecule (www.clinicaltrials.gov). As of September 2022, the IGC trial is the only ongoing Phase 2 trial of a natural THC-based formulation on Alzheimer’s patients.

The company’s other drug candidate, TGR-63, is an enzyme inhibitor that has shown in preclinical trials the potential to reduce neurotoxicity in Alzheimer’s cell lines. Both drug candidates have shown their ability to ameliorate beta amyloid plaques in Alzheimer’s cell lines and improve memory in Alzheimer’s mouse models. Beta amyloid plaques are a key hallmark of Alzheimer’s and an important target of Alzheimer’s pharmaceutical drug development.

Neuro Psychiatric Symptoms (NPS) are not only debilitating for Alzheimer’s patients; they also place an immense emotional burden on their caregivers. Beyond reducing symptoms, IGC-AD1’s active molecules and TGR-63 have also shown promise in preclinical trials to reduce important hallmarks of Alzheimer’s including plaques and tangles, as well as improving the treatment of memory loss.

Over the past eight years, the IGC team has amassed a deep knowledge of cannabinoid science, including extraction, isolation, purification, and development. The company’s strategy is to leverage its unique end-to-end capabilities, platform, and expertise to develop a class-leading program and bring it to market quickly and cost efficiently to treat neurodegenerative diseases such as Alzheimer’s.

The company also has a family of cannabidiol (CBD)-based consumer products (www.Holief.com) such as pain relief creams, pain relief gels, purpose gummies, tinctures, and capsules targeting women’s wellness, with a particular focus on premenstrual syndrome (PMS) and dysmenorrhea (period cramps). In addition, the company targets individuals that need sleep-aids with its specially formulated low melatonin cannabinoid gummies.

IGC has also introduced a low-calorie CBD- and caffeine-infused energy beverage brand (www.SundaySeltzer.com) that is currently available for purchase. The company’s brands are founded on the belief that effective natural solutions should be affordable and accessible to everyone. As the demand for natural products targeting women’s wellness and energy drinks continue to grow, these products are seeing strong traction in the market.

The company operates three facilities – a large GMP (Good Manufacturing Production Standards) certified facility that includes extraction, distillation, and manufacturing, in Washington State; a GMP-211 (pharmaceutical) grade facility in Maryland; and a facility licensed for controlled substances including cannabis in Bogota, Colombia, with complete access to legal licensed cannabis where the company conducts its testing.

In addition, the company’s development under Magistral Formulations is approved by INVIMA (Colombia National Food and Drug Surveillance Institute) to treat neurological disorders, non-oncological chronic pain, and mental disorders.

IGC’s intellectual property (IP) portfolio comprises of eight patents that it controls and seven patent applications. The portfolio includes #11,446,276, a patent for extreme low dose THC treatment of Alzheimer’s that was granted in September 2022.

The company is headquartered in Potomac, Maryland.

IGC-AD1

IGC-AD1 is the company’s leading drug candidate for the treatment and relief of Alzheimer’s symptoms. A significant amount of research on Alzheimer’s cell lines has shown that the active agents in IGC-AD1 reduce plaques and neurofibrillary tangles that are the hallmarks of Alzheimer’s. Further, micro-dosing of THC, as shown in cell lines, could increase the functioning of mitochondria and potentially promote the growth of new neural pathways (neurogenesis). The research shows that micro-dosing of THC affects the brain radically differently from the normal higher dosing of THC.

While there is a significant body of research showing that THC is neuro-toxic at normal levels of dosing, micro-dosing of THC has been shown to be non-toxic to neurons. With the results of these preclinical studies, the company developed an oral formulation, IGC-AD1. The company recently completed a safety and tolerability Phase 1 trial on Alzheimer’s patients and has initiated a Phase 2, multi-site, double-blind, randomized, placebo-controlled trial of the safety and efficacy of IGC-AD1 on agitation in participants with dementia due to Alzheimer’s disease at sites in the U.S. and Canada. IGC expects the Phase 2 trial to take between 9 and 12 months to complete, barring unknown factors such as, for example, a resurgence of COVID and the enforcement of lockdowns and travel restrictions.

With further successful trials and FDA approvals, IGC hopes to bring a drug based on natural THC as an effective treatment for agitation in Alzheimer’s to market.

TGR-63

The company’s other molecule, TGR-63, has been shown to reduce the neurotoxicity that impacts memory loss in preclinical trials with mice. On a dose dependent manner, transgenic Alzheimer’s mice treated with TGR-63 showed improvement in memory relative to control.

Both drug candidates, IGC-AD1 and TGR-63, have shown their ability to reduce the brain plaques associated with memory loss in Alzheimer’s in mice.

With further successful trials and FDA approvals, IGC hopes to bring TGR-63 as a treatment for Alzheimer’s disease to market.

Market Opportunity

Alzheimer’s disease impacts over 55 million people worldwide and about 5.5 million individuals in the U.S. Over 70% of these patients face debilitating symptoms, including anxiety, depression, and agitation (Mendez, 2021). Agitation in dementia patients can include excessive physical movement and verbal activity, restlessness, pacing, belligerence, aggression, screaming, crying, and wandering.

In 2020, the estimated healthcare costs for Alzheimer’s disease in the U.S. were $305 billion. Medicare and Medicaid covered about 70% of those costs, leaving considerable burden on patients and families. At the current rate of growth of Alzheimer’s and other dementia diagnoses, those costs are estimated to reach over $1 trillion by 2050.

Currently, there are no FDA-approved medications to alleviate the symptoms of dementia due to Alzheimer’s disease, providing a tremendous opportunity for formulations that can have an impact on quality of life and disease progression.

Management Team

Richard Prins has been chairman at IGC since 2012 and served as an independent director since 2007. From March 1996 to 2008, he was the Director of Investment Banking at Ferris, Baker Watts, Incorporated. Prins served in a consulting role to RBC until January 2009. He currently volunteers full time with a non-profit organization, Advancing Native Missions, and is a private investor. Since February 2003, he has been on the board of Amphastar Pharmaceuticals Inc. He holds a bachelor’s degree from Colgate University and an MBA from Oral Roberts University.

Ram Mukunda is CEO and President of IGC. He has been the chief inventor and architect of most of the company’s patent filings and is responsible for the company’s strategic positioning. Prior to IGC, he was founder and CEO of Startec Global Communications, which he took public in 1997. He served as Strategic Planning Advisor at Intelsat, a communications satellite services provider. From 2001 to 2003, he was a Council Member at Harvard’s Kennedy School of Government, Belfer Center of Science and International Affairs. He was named the 1998 Ernst & Young Entrepreneur of the Year. He holds bachelor’s degrees in electrical engineering and mathematics, and a master’s degree in engineering from the University of Maryland.

Dr. Jagadeesh Rao is the company’s Principal Scientist. His career spans two decades in the public sector and product R&D for Johnson & Johnson. He leads IGC’s scientists in the development of pharmaceutical and OTC products. He worked for the federal National Institutes of Health, and for the National Institute on Drug Abuse. His Ph.D. in Neurochemistry is from the National Institute of Mental Health & Neurosciences in India. He did postdoctoral training at the University of Illinois-Chicago.

Claudia Grimaldi is a Director, Vice President, Principal Financial Officer, and Chief Compliance Officer for IGC. She also serves as a Director/Manager Director for some of the company’s subsidiaries. She graduated with highest honors from Javeriana University in Colombia with a bachelor’s degree in psychology. She holds an MBA, graduating with highest honors, from Meredith College in North Carolina. In addition, she has attended the Darden School of Business Financial Management Executives program and the Corporate Governance Program at Columbia Business School. She is currently pursuing her Directorship Certification with the National Association of Corporate Directors. She is fluent in both English and Spanish.

India Globalization Capital Inc. (NYSE American: IGC), closed Thursday's trading session at $0.34, up 2.2556%, on 69,252 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.2785/$0.9353.

Recent News

Aditxt Inc. (NASDAQ: ADTX)

The QualityStocks Daily Newsletter would like to spotlight Aditxt Inc. (NASDAQ: ADTX).

Recent reports have indicated that the National Basketball Association (NBA) is striking cannabis from its list of banned drugs andending marijuana testing for players. Athletic and Stadium reporterShams Charania said that the NBA was removing cannabis testing as part of its newseven-year collective bargaining agreement and that the league hadeliminated marijuana from its antidrug testing program. The NBA’sstance on cannabis use among players has become more liberal inrecent years. Last October, it was reported that the NBA wouldpause random cannabis drug tests for the third time in a row. Some insiders posited that the NBA would soon make the policypermanent, with journalist Ben Dowsett saying at the time that hissources had informed him the decision to halt cannabis screeningwould not be rescinded in the near future. These speculations mayhave been right. In late 2020, NBA Commissioner Adam Silverindicated that the policy of scrapping cannabis tests would become permanent. This policy was initially implemented during the coronavirus pandemic when players were secluded in a quarantined bubble in Orlando to compete. These changes within the sporting fraternity come amidchanging attitudes at the general societal level, which have seenmarijuana companies thrive alongside ancillary enterprises such as Advanced Container Technologies Inc. (OTC: ACTX) in states where the drug is legal.

Aditxt Inc. (NASDAQ: ADTX) is a biotech innovation company developing technologies focused on mapping and reprogramming the immune system. Aditxt’s immune mapping technologies are designed to provide a personalized immune profile. Aditxt’s immune reprogramming technologies, currently preclinical, are being developed to retrain the immune system to induce tolerance to address rejection of transplanted organs, autoimmune diseases, and allergies.

As further discussed below, the company’s first commercial product is an immune mapping technology, AditxtScore™, which is designed to provide a personalized profile of the immune system.

The company’s preclinical immune reprogramming technology, Apoptotic DNA Immunotherapy™ (“ADi™”), aims to retrain the immune system to induce tolerance, with the goal of addressing vast unmet needs in transplanted organ rejection, autoimmune diseases, and allergies. The company is developing specific ADi™ products for psoriasis, type 1 diabetes, and skin grafting.

Headquartered in Richmond, Virginia, Aditxt also operates locations in Silicon Valley and New York.

AditxtScore™

AditxtScore™ is a proprietary platform designed to provide a personalized, comprehensive profile of an individual’s immune system. The underlying technology, licensed from Stanford University through an exclusive worldwide agreement, offers a highly sensitive and accurate method of detecting and quantifying cellular responses, allowing greater specificity, quantification, and amplification of both clinical and commercial opportunities.

The company’s first commercial application of the platform, AditxtScore™ for COVID-19, delivers timely reports on vulnerability and immune status relating to SARS-CoV-2 and its known variants, giving consumers and physicians the data needed to make informed health decisions. Potential future applications will offer early detection of an array of conditions, including diabetes, cardio-metabolic maladies and hormonal imbalances.

Aditxt’s AditxtScore™ immune monitoring center in Richmond, Virginia, is operational and designed to support the anticipated increased demand for AditxtScore™ as well as related products and services. The company is currently scaling its capabilities at this location, with a goal of processing up to 10 million immune system tests/reports annually.

ADi™

ADi™ is Aditxt’s immune reprogramming platform addressing disease-causing immune responses while maintaining the immune system’s ability to combat pathogenic infection. The company is commercializing a nucleic acid-based technology called Apoptotic DNA Immunotherapy™ (ADi™) which utilizes a novel approach that mimics the way our bodies naturally induce tolerance to our own tissues (therapeutically induced immune tolerance). Aditxt believes its ADi™ technology platform can be engineered to address a wide variety of indications.

Aditxt is currently developing ADi™ products for psoriasis, type 1 diabetes and skin grafting.

Currently, immuno-tolerance is achievable through chimerism and cell-based therapy, but there is a clinical need for a more practical and cost-effective approach which:

  • Can be made into a product
  • Does not require additional hospitalization
  • Is simple to produce and ship

Preclinical studies have demonstrated that ADi™ treatment significantly and substantially prolongs graft survival, in addition to successfully “reversing” other established immune-mediated inflammatory processes. ADi™ treatment is not expected to require hospitalization, instead being delivered as an injection in minute amounts into the skin.

IP Portfolio

Both AditxtScore™ and ADi™ are supported by a strong IP portfolio.

AditxtScore™, built upon initial technology invented, licensed from and used at Stanford University, is protected by U.S. patents encompassing methods, systems, and kits for detection and measurement of specific immune responses.

ADi™ technology is protected by seven patent families, including:

  • 8 U.S. patents
  • 4 pending U.S. patent applications
  • 86 foreign patents and 14 pending foreign patent applications spanning the EU, Australia, Canada, Japan, China, India and Hong Kong

These patents are broadly categorized into three groups:

  • Autoimmune diseases and Type 1 Diabetes
  • Organ transplantation and a method of producing plasmid DNA to prevent immune activation
  • Composition of matter for a tolerance delivery system for antigens of interest

Aditxt also possesses and/or in-licenses substantial know-how and trade secrets relating to the development and commercialization of its product candidates, including related manufacturing processes and technologies.

Market Overview

The potential market opportunities presented by immune monitoring and reprogramming are extensive, particularly as Aditxt continues to evaluate additional applications for the platforms.

The company’s initial focus on organ transplantation and related autoimmune response provides some insight into the potential of its approach. According to BCC Research, the global organ and tissue transplantation and alternatives market is on course to reach $120.3 billion by 2024, recording a CAGR of 7.4% from 2019. Industry data suggest that approximately 50% of all transplanted organs are rejected within 10-12 years, further highlighting the critical need for a practical, cost-effective solution to harmful autoimmune responses.

Through its focus on the COVID-19 testing market with AditxtScore™, Aditxt demonstrated the wide-ranging potential of its portfolio. Fortune Business Insights estimated the global COVID-19 diagnostics market at $48.64 billion for 2022. While demand for COVID-19 diagnostics is expected to lessen in the coming years, Aditxt will be uniquely positioned to leverage its existing infrastructure stemming from these operations as the company works to advance broader applications for the AditxtScore™ platform.

Leadership Team

Amro Albanna is the Co-Founder, Chairman, and CEO of Aditxt. He has founded multiple startups to commercialize innovations in various industries, including healthcare, enterprise software, telecommunications, nano technology, consumer health, and biotech. Mr. Albanna has led numerous M&A and going-public transactions as a founder, co-founder, and senior executive.

Shahrokh Shabahang, D.D.S., MS, Ph.D., is the company’s Co-Founder, Chief Innovation Officer, and a member of its board. He brings to the team more than 20 years of experience in developing and commercializing life science technologies focused on product and clinical development in the fields of microbiology and immunology.

Corinne Pankovcin, CPA, MBA, is the President of Aditxt. Prior to joining Aditxt, Ms. Pankovcin served as CFO for several world class organizations, including Business Development Corporation of America, Blackrock Kelso Capital and AIG Capital Partners. In these roles, Ms. Pankovcin was responsible for executing portfolio investments and managing significant M&A transactions.

Thomas Farley is the Chief Financial Officer of Aditxt. From December 2015 to June 2020, Mr. Farley was the Controller and Treasurer of Business Development Corporation of America (“BDCA”), a publicly listed business development company. Prior thereto, from January 2011 to August 2015, Mr. Farley was the Senior Controller of Blackrock Capital Investment Corporation (NASDAQ: BKCC). Prior to joining BlackRock Capital Investment Corporation, Mr. Farley was a Senior Controller for PineBridge Investments Emerging Markets practice. Mr. Farley was also an Accounting Manager for Bessemer Venture Partners prior to his tenue at PineBridge. Mr. Farley began his career with PricewaterhouseCoopers LLP, from 1996 to 2001. Mr. Farley earned his B.S. in Accounting from Long Island University and is a Certified Public Accountant.

Rowena Albanna is the company’s Chief Operating Officer. Ms. Albanna has over two decades of experience in senior leadership roles for both technology startups and public companies. Ms. Albanna’s experience spans a wide variety of industries, including biotechnology, insect control, nanotechnology, consumer electronics, financials, telecommunications, e-commerce, online marketing, medical, and defense.

Matthew Shatzkes is the Chief Legal Officer and General Counsel of Aditxt. As a former partner at an AM Law 50 law firm, Mr. Shatzkes advised a wide variety of healthcare related entities, including biotech companies, on corporate, regulatory, and strategic business matters. Mr. Shatzkes will oversee all aspects of the legal functions at Aditxt, including, providing advice and counsel on governance, regulatory matters, strategic alliances, mergers and acquisitions, and commercial transactions.


Aditxt Inc. (NASDAQ: ADTX), closed Thursday's trading session at $0.3, even for the day, on 17 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.073/$1.25.

Recent News

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX)

The QualityStocks Daily Newsletter would like to spotlight McEwen Mining Inc. (NYSE: MUX) (TSX: MUX).

McEwen Mining is an asset-rich diversified gold and silver producerin the Americas with significant exposure to copper through its51.9%-owned McEwen Copper

McEwen Copper holds 100% interest in the Los Azules Project inArgentina, which has been shown to have many attributes comparableto world-class copper-gold deposits in South America

The subsidiary is advancing the Los Azules Project and has beenundertaking infill and step-out exploration drilling

McEwen Copper’s focus comes at a time when the world is staring atcopper deficits driven by constrained supply amid politicalinstability in top copper-producing countries and increased demand

Copper, a base metal with no obvious substitute, is found incountless products in homes, offices, manufacturing plants, andvehicles. For context, a typical home contains over 400 pounds(about 180 kilograms) of the metal, with most of thesecopper-containing products being electronics that need to bepowered by electricity tapped from an electricity grid that majorlycomprises components that are made using copper (https://ibn.fm/Ng9Yv). Copper is also used to manufacture military vehicles like ships,naval vessels, and aircraft because it is resistant to corrosion.As the world targets a green transition, more sectors are lookingto decarbonize, opting to electrify to reduce use of fossil fuels.As a result, millions of feet of copper wiring will be needed tobuild complex grids that can handle the growing electricity needs.Sights are also set on electric vehicles, which use about two tofour times more copper than the average internal combustion engine(“ICE”)-powered vehicle. Against this backdrop of increased demand,an article in Investing News notes the prospects for the base metal are bright both in theshort and long term (https://ibn.fm/uK2v5). How well the supply will keep up with the demand is an openquestion, with a recent CNBC article warning about the possibilityof a copper deficit continuing throughout 2023 and even beyond (https://ibn.fm/H5SjU). Most mines are located in the political hot zones of SouthAmerica – Chile, the top copper producer, for example, has beenexperiencing political instability since 2019, while Peru, thesecond top copper-producing country, is drowning in ongoing unrest.Additionally, besides being primarily located in these volatileregions, the top 10 mines in the world are getting deeper everyyear, translating to increased mining expenses, yet the copperbeing extracted is of a lower grade. Combined, these factorsrepresent a supply bottleneck that McEwen Copper, a base metaldeveloper 51.9% owned by McEwen Mining (NYSE: MUX) (TSX: MUX), is looking to solve by advancing its 100%-owned Los AzulesProject in the San Juan Province of Argentina.

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) is an asset rich diversified gold and silver producer in the Americas and has a large exposure to copper through its subsidiary, McEwen Copper, owner of the Los Azules copper deposit in Argentina, believed to be the 9th largest undeveloped copper resource in the world.

Led by a management team with a track record of success, MUX owns and operates mines in some of the most prolific gold producing regions in the Americas. In recent months, the company has undertaken strong actions to lower production costs and increase production across its portfolio of gold assets, driving some costs below the industry average. Gold and copper prices are forecast to enter a major uptrend over the next couple years. McEwen Mining is laying the groundwork to capitalize on this opportunity now.

Seldom is management so aligned with investors’ interests with a commitment to the company’s success. CEO Rob McEwen maintains a 17% ownership stake in McEwen Mining and a 15% ownership in McEwen Copper with a combined cost base of roughly $220 million. McEwen founded Goldcorp, where he took the company from a market capitalization of $50 million to over $8 billion, and that same vision led MUX to create McEwen Copper.

For McEwen Mining shareholders, the company’s 68% stake in McEwen Copper is expected to be a gamechanger, turbocharging MUX by creating the world’s next copper unicorn.

McEwen Copper

Most mined copper is currently used in infrastructure, with new critical demand emerging for use in the electrification of transportation and the global energy transformation. The price of copper rose from a low of about $2 per pound two years ago to over $4 per pound today, and strong demand is expected to continue to soar. A study by S&P Global, titled The Future of Copper: Will the Looming Supply Gap Short-circuit the Energy Transition?, projects global copper demand to nearly double over the next decade, from 25 million metric tons today to about 50 million metric tons by 2035. Based on current trends, S&P Global projects annual supply shortfalls to reach nearly 10 million metric tons in 2035.

McEwen Mining is a 68% shareholder in McEwen Copper, holder of a 100% interest in the Los Azules copper project in San Juan, Argentina, which was ranked the 9th largest undeveloped copper deposit in the world by Mining Intelligence (2022). Its current copper resources are estimated at 10.2 billion pounds at a grade of 0.48% Cu (Indicated category) and an additional 19.3 billion pounds at a grade of 0.33% Cu (Inferred category). McEwen Copper also owns a copper exploration project in Nevada, called Elder Creek.

In a 2017 Preliminary Economic Assessment (PEA), Los Azules was estimated to have a 36-year life, but indications are that the project could ultimately become an even larger mine, with a longer life, since in the assessment, only 55% of the known copper resources are to be mined. Numerous drill holes have shown strong copper mineralization extending below the PEA pit bottom. Its average annual production for its first 13 years was pegged at 415 million pounds of copper in the 2017 PEA – enough copper to supply 2.2 million electric vehicles per year.

In August 2022, McEwen Copper closed its non-brokered, private placement offering of $82 million, after securing a $25 million investment from mining giant Rio Tinto’s technology arm, Nuton LLC. This gives McEwen Copper an imputed value of $258 million, which would give McEwen Mining’s 68% interest a value of approximately $3.70/share. Additional value can be attributed to McEwen Mining’s 1.25% net smelter royalty on both the Los Azules and the Elder Creek projects.

“We completed an $82 million financing for McEwen Copper in a very tough equity market. Rio Tinto, the second largest mining company in the world, through its subsidiary Nuton, now owns 9.7% of McEwen Copper, a result of its investment of $25 million,” Rob McEwen stated in a news release. “Also, Nuton is testing the Los Azules copper mineralization to see if it can accelerate and increase copper recoveries. Another of Rio Tinto’s subsidiaries, Kennecott Exploration, signed an option to earn a 60% interest in McEwen Copper’s other copper project, Elder Creek, by spending $18 million on exploration.”

The Elder Creek project is prospective for porphyry copper and gold mineralization and is well situated in a district hosting several large copper and gold mines, including Marigold, Lone Tree and Phoenix. Kennecott Exploration will be the operator of the exploration program. McEwen Mining holds a 1.25% net smelter return (NSR) royalty on the Elder Creek property.

Following the capital raise, McEwen Copper is well-funded to advance its Los Azules Project. Publication of an updated PEA on the Los Azules copper project is planned for Q1 2023. In Q2, an IPO is planned, along with MUX completing a secondary offering, assuming no further private placements in the interim. MUX is strategically reducing its interest to increase its treasury, in order to reduce debt and fund the further development of its gold and silver mines.

McEwen Copper currently has an implied market cap of over $258 million, based on its most recently completed financing. However, when its Los Azules copper project is compared with other recent transactions and market valuations of copper projects in the same region, it appears very undervalued.

MUX’s management believes its ownership stake in McEwen Copper is not currently reflected in the share price of the company. In fact, it is management’s belief that the combined value of its 68% interest in McEwen Copper, plus its gold mines and portfolio of mineral royalties, represents a share value ranging from a low of $8 to a high of $30 per share. Rob McEwen provides a full breakdown of this valuation estimate in a news release detailing the company’s Q3 2022 results.

Gold & Silver Projects

The Fox Complex

McEwen Mining owns a 100% stake in the Fox Complex in the heart of a prolific gold district in Timmins, Canada.

“When MUX bought the Fox Complex, in late 2017, it was a distressed asset with a history of high operating cost/oz. While it has taken longer than I expected, the cost to produce an ounce of gold is significantly lower,” CEO Rob McEwen stated in a news release. “I am pleased to say that in Q3 our cash cost/oz at Fox fell to $774, our lowest since mid-2018. This is well below the industry average. With our mine operating much more efficiently, our next important area to improve at Fox is the process plant (mill). Specifically, we need to increase the throughput because our mine is now producing more ore than our mill can process. As a result, we have a large surface stockpile of ore equivalent to more than two months of production.”

This ore stockpile contains approximately 10,000 ounces of gold representing a potential source of $12 million in free cash flow.

Located in one of the most prolific gold production areas in the world, along the Destor-Porcupine Fault Zone within the Abitibi Greenstone Belt, the Fox Complex includes the Black Fox mine and Froome mine which together have, so far, produced in excess of 1,000,000 ounces of gold. Also, it includes the Grey Fox and Stock deposits that have an estimated additional 1,600,000 ounces in reserves and resources. The 2.7-billion-year-old Abitibi Greenstone Belt, formed by ancient volcanic activity, has proved to be one of the world’s richest and most abundant gold regions, boasting total gold content of over 300 million ounces.

Full year 2023 guidance for The Fox Complex puts production estimates at 45,000 GEOs, 28% of MUX’s total production.

The Gold Bar Mine

McEwen Mining owns a 100% stake in the Gold Bar mine located in an area well known for gold production, the southern Roberts Mountains of the Battle Mountain-Eureka-Cortez gold trend in Eureka County, Central Nevada. The Gold Bar mine is on the same geological structure some 25 miles south of Nevada Gold Mines, a joint venture of Barrick and Newmont. This Cortez-Goldrush complex contains estimated reserves and resources of greater than 50 million gold ounces. Its annual gold production is 1,000,000 ounces.

Gold Bar had been previously mined, between 1991 and 1994, producing 134,000 gold ounces. MUX built a new facility in 2019. The open pit mine was expected to be a large contributor to MUX’s revenue and gold production, however operating challenges arose that reduced gold production and drove cost/oz unacceptably high. Mining activities have shifted recently to a nearby, satellite deposit called Gold Bar South (GBS). Going forward the expectations are higher gold production and lower operating cost/oz as a result of mining a higher ore grade (concentration of gold per ton) and having to move half the amount of material to capture an ounce of gold.

“At Gold Bar, we are looking forward to starting to mine our GBS deposit this quarter,” McEwen said in a November 2022 release. “We are expecting to have a much lower cost/oz than our YTD cost because we will be mining higher grade ore at GBS, with half the strip ratio and no problematic carbonaceous material.”

The Gold Bar Mine will account for approximately 28% of McEwen Mining’s 2023 total attributable production, with guidance pegged at 45,000 GEOs. Most of Gold Bar production in 2023 will be from GBS.

El Gallo/Fenix

Project Fenix is the proposed redevelopment plan for McEwen Mining’s El Gallo Complex in Mexico. There is a long history of mining in this region. MUX’s involvement began in 2013 operating it as an open pit, heap leach mine which produced 281,000 gold equivalent ounces at average cash cost of $655 per ounce. However, due to the transition to deeper sulfide mineralization that is not amenable to heap leaching, mining activities ceased in the second quarter of 2018. The redevelopment envisions constructing a mill at the existing mine site that will initially reprocess the existing heap leach material then transition to open pit mining and processing the sulphide mineralization. The company recently acquired a complete process plant on very advantageous terms that has considerably reduced the projected capital requirements for the project.

CEO Rob McEwen stated in a news release, “This acquisition has made Fenix more attractive to build and could provide a new long life mine for McEwen Mining.”

The initial development approach is to build a mill to reprocess the material on the heap leach pad and produce approximately 17,000 oz of gold annually for eight years. Construction of the Fenix project is expected to be completed by early 2024.

Mine San José

McEwen Mining is a 49% owner and non-operator of the San José gold and silver mine located in Santa Cruz province, Argentina. This high-grade underground mine has been operating since 2007 and currently has an expected life of six years with a reserve grade of 342 gpt silver and 5.7 gpt gold and a resource grade of 427 gpt silver and 7.0 g/t gold.

“The San José mine, where we have a 49% interest, put in a strong quarter and its exploration is continuing to extend its high-grade veins and discover new veins,” McEwen noted in a news release.

Production guidance for 2023 for MUX’s 49% is 70,000 GEOs, 44% of MUX’s total production. As a minority shareholder in the mine, MUX equity accounts for its investment in San Jose, and it receives 49% of the dividends from the mine’s free cash flow.

Market Outlook

Mining stocks took a beating in the wake of the COVID-19 pandemic. However, that could change, as many analysts are now forecasting a gold bull market in 2023.

“The operating challenges we faced in recent years have severely damaged our credibility with our shareholders and the market. As a result, few investors have taken a close look recently at our assets,” Rob McEwen said in a news release. “If they did, I believe some would see the potential value that I see today… I believe there is considerable potential value in MUX, and that is a big reason why I have a personal financial commitment of $220 million in MUX and McEwen Copper.”

Management Team

Robert R. McEwen is Chairman, CEO and Chief Owner of McEwen Mining. He has been associated with the gold industry all his career, with his first 18 years in the investment industry and, since 1990, as CEO of several gold mining companies. He founded Goldcorp and took that company from a $50 million market capitalization to more than $8 billion. He owns 17% of McEwen Mining and is in complete alignment with investors – the cost of his investment in MUX and McEwen Copper is $220 million and he takes an annual salary of only $1. He was awarded the Order of Canada and the Queen Elizabeth’s Diamond Jubilee Award, was inducted into the Mining Hall of Fame, was named an Ernst and Young Entrepreneur of the Year and has Honorary Doctor of Law degrees from York University and Western University.

William Shaver is interim COO and a Director of McEwen Mining. He has decades of management and executive experience in mine design, construction and operations. He was a founder of Dynatec Corporation, which became one of the leading contracting and mine operating groups in North America. In 2013, he was recognized as Ernst and Young Entrepreneur of the Year. Most recently, he served as COO of INV Metals. He is a Professional Engineer with a B.Sc. in Mining Engineering from Queens University.

Perry Ing is interim CFO at McEwen Mining. He has 25 years of experience in the Canadian mining industry. Over the past 15 years, he has held positions as CFO of Mountain Province Diamonds, Kirkland Lake Gold and McEwen Mining. Prior to that, he worked at Barrick Gold and Goldcorp and started his career in the mining practice at PwC. He has a Bachelor of Commerce from the University of Toronto and is a Chartered Professional Accountant in Canada and Certified Professional Accountant in the U.S.

Adrian Blanco S. is the company’s Director – America and Mexico Operations. He has extensive international experience in several industrial sectors and has held executive positions in Mexico, the United States, Peru and Argentina. He joined the McEwen Mining team in 2015 and has led a successful business transformation toward operational discipline, best business practices and financial profitability at subsidiaries Compañia Minera Pangea and McEwen Mining Nevada. He graduated from an Executive Management Program at IPADE and Harvard Business School.

Michael Meding is Vice President and General Manager of McEwen Copper. He has over 20 years of international experience, primarily with major mining companies such as Barrick Gold and Trafigura, including extensive experience with project development and operations in Argentina. While at Barrick Gold’s Veladero mine in Argentina, Mr. Meding played a key role in the turnaround, extension of the mine life and subsequent strategic partnering with Shandong Gold. He holds an MBA from Indiana University in Pennsylvania and an MBA from the Leipzig Graduate School of Management in Germany.

McEwen Mining Inc. (NYSE: MUX), closed Thursday's trading session at $9.09, off by 1.6234%, on 446,123 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $2.81/$9.455.

Recent News

Freight Technologies Inc. (NASDAQ: FRGT)

The QualityStocks Daily Newsletter would like to spotlight Freight Technologies Inc. (NASDAQ: FRGT).

Freight Technologies (NASDAQ: FRGT), a technology company offering its custom-developed Fr8App, anindustry-leading freight-matching platform that offers a B2Bcloud-based solution for cross-border and domestic shipping withinthe USMCA region, saw a record increase in the number of newshipper clients added during March 2023. The company reported thatthe increase comes after a “challenging first quarter” and includeclients from an array of sectors, including automotive, beverage,motorcycles and consumer goods. According to the announcement, thecompany is reporting $4.4 million in quarterly revenue for Q4 2022with YTD 2022 revenue totaling $25.9 million, an increase of 20.6%from the prior year. Management also shared its 2023 revenueguidance of $36 million, representing a nearly 40% growth fromFr8App’s 2022 full-year revenue. “The new shipper clients representa potential for significant recurring traffic on our platform andinclude leading first-tier automotive clients, renowned motorcyclebrands and cocktail drinks — most of whom are household names,”said Freight Technologies sales director Harry Martin in the pressrelease. “We expect a recurring monthly stream from new accounts toour platform during the month of March of more than $1 million permonth, starting to ramp in April. . . . On the Mexico domesticmarket, we had confirmations of existing clients for our Fr8fleetbusiness to continue growing through the rest of 2023, and requestsfor new services from existing shipper clients in the domesticMexican markets equivalent to almost the entire Fr8fleet 2022revenue. We have been tirelessly working on getting these key largeshipper clients on our platform, and we are pleased to announce thesigning of a number of key accounts, which will help attractcarrier activity onto our platform as well.”

To view the full press release, visit https://ibn.fm/bEBUM

Freight Technologies Inc. (NASDAQ: FRGT) (“Fr8Tech”) is a technology company developing solutions to optimize and automate the supply chain process, providing a platform for B2B cross-border shipping in the NAFTA region. The company’s mission is to revolutionize cross-border shipping by providing carriers with increased growth opportunities and shippers with flexibility, visibility and simplicity for the once-complex process of international over-the-road shipping.

Freight Technologies, formerly known as Hudson Capital Inc., assumed its current name and ticker symbol on May 27, 2022. Its primary operating subsidiary and its marketplace are known as Fr8App, and it conducts operations throughout North America under the names of Fr8App and/or Freight App. The company is headquartered in Houston, Texas, with multiple locations across the U.S. and Mexico.

The Fr8Tech Solutions Suite

Fr8Tech leverages artificial intelligence to provide cloud-based platforms aimed at automating the over-the-road transportation process, effectively reducing human touch points and expediting load booking times. The company’s suite of solutions includes:

  • Fr8app – A B2B marketplace powered by AI and Machine Learning offering a real-time broker portal to connect shippers with qualified carriers
  • Fr8Radar – A tracking solution providing shippers and carriers real-time locational data via Fr8app’s mobile solution or through integration with third-party GPS alternatives
  • Fr8TMS – A transportation management system designed to help shippers manage their freight and all of the documents involved in shipping transactions, including invoices, customs documents, confirmation rates and proof of deliveries
  • Fr8FMS – A fleet management system allowing transportation companies to better manage their fleets, reduce operational costs and provide better service to their customers
  • Fr8Data – A data solution offering real-time dashboards and reports to shippers and carriers in an effort to increase visibility and control while supporting better business decisions
  • Fr8Fleet – A platform that provides private fleet management, enabling large corporate shippers to purchase dedicated capacity secured by Fr8app in exchange for a fixed fee

Commitment to the Environment

Through its core focus on technology, Fr8Tech seeks to reduce the carbon footprint of the logistics industry. Its solutions aim to minimize empty miles for transportation firms and reduce overall paper consumption.

Fr8University

Fr8University is an educational program offering classroom and on-the-job training for Fr8Tech team members. Through the program, employees learn in-depth business fundamentals and applications along the truckload freight industry value chain.

Led by corporate educator Mario Mena, Fr8University is designed as an investment in the company’s human capital, providing an opportunity to communicate Fr8Tech’s corporate culture while accelerating operational growth.

Market Outlook

Fr8Tech’s established foothold in Mexico is key to its current efforts to promote sustainable growth in the cross-border shipping industry. Ongoing disruption in U.S.-Chinese trade relations have strengthened Mexico’s status as the largest trading partner of the U.S., with cross-border annual freight spending estimated at $385 billion according to data from the U.S. Department of Transportation. Annual domestic shipping in Mexico is estimated at $34 billion, while annual domestic shipping in the U.S. is estimated to total $732 billion.

Despite the size of this industry, fragmentation and inefficiencies prevail in the space. Thousands of legacy brokers, tens of thousands of shippers and hundreds of thousands of carriers still rely on outdated systems to arrange transport, spending hours on the phone negotiating pricing, waiting days to find trucks and drivers, preparing and printing forms, and operating without tracking or visibility. Add in cross-border complexity relating to customs and additional paperwork, and you have an industry ripe for technological disruption.

Fr8Tech’s recent revenue growth trends have highlighted the company’s efforts to capitalize on this opportunity. In 2021, Fr8Tech achieved revenues of $21.5 million, marking a year-over-year increase of 134%. The company issued revenue guidance for fiscal 2022 of $40 million in a February 9, 2022, press release, which would account for a further 86% year-over-year increase.

Management Team

Javier Selgas is CEO and a Director of Freight Technologies Inc. and Freight App Inc. He brings to the company over 15 years of experience developing technology and digital marketing strategies, including serving as Country Manager for Osigu, Spain, and as head of AJEgroup’s IT division for the Asia-Pacific region. Prior to joining Fr8Tech, Mr. Selgas founded digital marketing agency Lanzadera Online. He has also served as an IT consultant to major corporations, including Endesa and Ibermatica.

Mike Flinker is President of Fr8Tech. He has over four decades of experience in the transportation industry, with 30+ years focused on cross-border logistics. Prior to joining Fr8Tech, Mr. Flinker founded FLS Transportation, the largest cross-border logistics company in Canada. He also previously held positions with Clarke Transport Inc., Canadian Pacific and Reimer Express Inc. (a division of Roadway Express).

Paul Freudenthaler is the company’s CFO and Secretary to the company Board. He has over 30 years of financial expertise, having previously served as CFO for several leading companies across multiple countries, including Macquarie in Mexico, Old Mutual in Latin America and Ascentium Capital in the U.S. Mr. Freudenthaler’s experience include leadership roles from which he guided IPOs and M&A transactions.

Luisa Lopez is COO of Fr8Tech. She brings to the company 25+ years of management experience in logistics, supply chain, operations and customer service. Ms. Lopez previously served as a Director of Landstar, where she was responsible for commercial and client development strategies in the Mexican market. Additionally, she managed more than 2,000 transport units specialized in staff and school mobility while with Traxion in Mexico.

Freight Technologies Inc. (NASDAQ: FRGT), closed Thursday's trading session at $2.14, off by 4.0359%, on 1,457,967 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $1.3424/$31.512.

Recent News

CNS Pharmaceuticals Inc. (NASDAQ: CNSP)

The QualityStocks Daily Newsletter would like to spotlight CNS Pharmaceuticals Inc. (NASDAQ: CNSP).

CNS Pharmaceuticals (NASDAQ: CNSP) today announced its receipt of approval from the Italian MedicinesAgency (“AIFA”) Competent Authority and the A.O.U. Policlinico diBari Ethics Committee for its ongoing potentially pivotal globaltrial evaluating Berubicin for the treatment of recurrentglioblastoma multiforme (“GBM”), an aggressive and incurable formof brain cancer. According to the update, the company plans to openits clinical sites in Italy imminently in addition to thepreviously opened 41 clinical trial sites of the 60 selected acrossthe U.S., France, Spain, and Switzerland. “Our team has continuedto make dedicated efforts to build momentum and drive patientenrollment in this important clinical trial. We are incrediblypleased to add Italy to our growing portfolio of European countriesfor this global study,” said John Climaco, CEO of CNSPharmaceuticals. “Our team continues to focus on bringingadditional clinical trial sites online to further accelerate ourpatient enrollment and our advance toward our planned interimanalysis, which we expect in the third quarter of 2023. We lookforward to getting sites up and running in Italy in the nearfuture. We remain dedicated to advancing Berubicin and potentiallyaddressing the unmet need in the treatment of GBM.”

To view the full press release, visit https://ibn.fm/K4Tr5

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system.

The company was founded in 2017 and is headquartered in Houston, Texas.

Organ Targeted Therapeutics

The company’s lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. Berubicin also has potential to treat other central nervous system malignancies. Based on limited clinical data, Berubicin appears to be the first anthracycline to cross the blood brain barrier in the adult brain, and it was the subject of a successful Phase 1 study which found the MDT and produced efficacy data as well.

CNS holds a worldwide exclusive license to the Berubicin chemical compound. The company has acquired all requisite data and know-how from Reata Pharmaceuticals Inc. related to a completed Phase I clinical trial of Berubicin in malignant brain tumors. In this trial, 44% of patients experienced a statistically significant improvement in clinical benefit. In 2017, CNS entered into a collaboration and asset purchase agreement with Reata.

CNS intends to explore the potential of Berubicin to treat other diseases, including pancreatic and ovarian cancers and lymphoma. The company is also examining plans to develop combination therapies that include Berubicin.

CNS estimates that more than $25 million in private capital and grants were invested in Berubicin prior to the company’s $9.8 million IPO in November 2019.

CNS intends to submit an IND for Berubicin during the fourth quarter of 2020 and expects to commence a Phase II clinical trial of Berubicin for the treatment of GBM in the U.S. in Q1 2021. A sub-licensee partner was awarded a $6 million EU/Polish National Center for Research and Development grant to undertake a Phase II trial of Berubicin in adults and a first-ever Phase I trial in pediatric GBM patients in Poland in 2021.

The company’s second drug candidate, WP1244, is a novel DNA binding agent licensed from the MD Anderson Cancer Center. In preclinical studies, WP1244 proved to be 500-times more potent than the chemotherapeutic agent, daunorubicin, in inhibiting tumor cell proliferation. The company has entered into a sponsored research agreement with the MD Anderson Cancer Center to further the development of WP1244.

CNS Pharmaceuticals recently engaged U.S.-based Pharmaceutics International Inc. and Italian BSP Pharmaceuticals SpA for the production of the Berubicin drug product. The company has implemented a dual-track manufacturing strategy to mitigate COVID-19-related risks, diversify its supply chain and provide for localized availability of Berubicin. CNS has already completed synthesis of Berubicin’s active pharmaceutical ingredient (API) and has shipped the API to both manufacturers in order to prepare an injectable form of Berubicin for clinical use.

Global Brain Tumor Therapeutics Market

The high recurrence rate of malignant brain tumors is due to reappearance of focal masses, indicating that a sub-population of tumor cells in these cancers may be insensitive to current therapies and may be responsible for reinitiating tumor growth. This necessitates the development of newer drugs in the market that demonstrate greater efficacy in treating such aggressive cancers.

A global increase in neurological disorders has placed increased attention on cancers of the brain over the past decade. Neurological disorders are becoming one of the most prevalent types of disorders, due to longer life expectancy, greater exposure to infection and an increasingly sedentary lifestyle. Because few treatments for primary and metastatic cancers of the brain exist, costs are high and have acted as a restraint for the brain tumor therapeutics market.

Despite progress in surgery, radiotherapy and chemotherapeutic strategies, effective treatments for brain cancer are limited by a lack of specific therapies for the brain and the difficulty in transporting therapeutic compounds across the blood brain barrier. Therefore, there is a significant need for novel and effective therapeutic drugs and strategies that prolong survival and improve quality of life for brain tumor patients.

Several companies are making significant investments into R&D, which is expected to bring more treatment options to the market in the near future. Industry reports consistently project continued growth in the market.

One report estimates that the global brain tumor therapeutics market will reach a valuation of $2.74 billion in 2023, with the market expected to register a CAGR of 11% during the forecast period from 2018 to 2023. Another report projects that the global brain tumor therapeutics market will reach $3.4 billion by 2025, up from $2.25 billion in 2019 (http://nnw.fm/eDUjp).

Management Team

John M. Climaco is the CEO of CNS Pharmaceuticals. For 15 years, Climaco has served in leadership roles for a variety of health care companies. Recently, Climaco served as the Executive Vice President of Perma-Fix Medical S.A, where he managed the development of a novel method to produce Technitium-99. Climaco also served as President and CEO of Axial Biotech Inc., a DNA diagnostics company. In the process of taking Axial from inception to product development to commercialization, Climaco forged strategic partnerships with Medtronic, Johnson & Johnson and Smith & Nephew.

Christopher Downs, CPA, is the company’s Chief Financial Officer. Downs previously served as Interim Chief Financial Officer and Executive Vice President of InfuSystem Holdings Inc. (NYSE: INFU), a supplier of infusion services to oncologists in the United States. Downs holds a Bachelor of Science from the United States Military Academy at West Point, an MBA from Columbia Business School and a Master of Science in Accounting from the University of Houston-Clear Lake.

Dr. Donald Picker is the Chief Scientific Officer of CNS. Picker has over 35 years of drug development experience. Prior to joining CNS, Picker worked at Johnson Matthey, where he was responsible for the development of Carboplatin, one of the world’s leading cancer drugs, which was acquired by Bristol-Myers Squibb with annual sales of over $500 million. In addition, he oversaw the development of Satraplatin and Picoplatin, third-generation platinum drugs currently in late-stage clinical development.

Sandra L. Silberman, M.D., Ph.D., is the Chief Medical Officer of CNS Pharmaceuticals. Silberman is a hematologist/oncologist who earned her B.A., Sc.M. and Ph.D. from the Johns Hopkins University School of Arts and Sciences, School of Public Health and School of Medicine, respectively, and her M.D. from Cornell University Medical College. She then completed both a clinical fellowship in hematology/oncology and a research fellowship in tumor immunology at the Brigham & Women’s Hospital and the Dana Farber Cancer Institute in Boston, Massachusetts. Silberman has played key roles in the development of many drugs, including Gleevec(TM), for which she led the global clinical development at Novartis. Silberman advanced several original, proprietary compounds into Phases I through III during her work with leading biopharmaceutical companies, including Bristol-Myers Squibb, AstraZeneca, Imclone and Roche.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP), closed Thursday's trading session at $0.7501, off by 13.3834%, on 12,652,814 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.7011/$13.425.

Recent News

Knightscope, Inc. (NASDAQ: KSCP)

The QualityStocks Daily Newsletter would like to spotlight Knightscope, Inc. (NASDAQ: KSCP).

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) andblue light emergency communication systems, received three newpurchase orders for its K1 emergency communication systems. Thecompany also deployed another K5 ASR at a healthcare facility. Thisgrowth is symbolic of the company’s growing momentum and increasingsales in an array of sectors. The K1 orders came from VIA MetroTransit of San Antonio, Texas; authorized partner Embry-RiddleAeronautical University in Florida; and a New-Mexico-based publictribal land-grant community college.

The company noted that the ASR was sent to an existing Ohio-basedhealthcare client — a pharmaceutical’s global manufacturer anddistributor of medical and laboratory products, and provider ofperformance and data solutions for healthcare. The add-on K5 ASRwill be surveilling a second location to provide perimeterprotection in the parking lot around its facility.

In addition, the Knightscope’s robot roadshow will be moving fromBroadway to the boardwalk. After concluding its debut at TimesSquare, the tour heads to New Jersey’s famous boardwalk, where itsspace-age, climate-controlled “Pod” will be set up at the ResortsCasino Hotel from April 18–20, 2023. Public viewing for the RobotRoadshow will be 10 a.m. – 2 p.m. ET.

Knightscope CEO and chair William Santana Li is also wrapping upthe last few days of the company’s 10 Town Halls, scheduled as partof KSCP’s 10th anniversary. During the online events, Li willanswer questions from supporters, investors and analysts in anintimate online forum with no moderator. The town halls arescheduled over several different time periods and dates toaccommodate busy schedules of those who are interested inattending.

To sign up for a town hall, visit https://ibn.fm/hlBjf

To sign up for a roadshow slot, visit https://ibn.fm/XHflA

To view the full press release, visit https://ibn.fm/MLW5C

Knightscope, Inc. (NASDAQ: KSCP), founded in 2013 and based in Mountain View, California, is a leader in the development of autonomous security capabilities targeting to disrupt the $500 billion security industry. Knightscope’s technology uniquely combines self-driving technology, robotics, artificial intelligence and electric vehicles.

Knightscope designs and builds Autonomous Security Robots (ASRs) that provide 24/7/365 security to the places you live, work, visit and study. The company’s client list covers public institutions and commercial business operations, including multiple Fortune 1000 companies to date. These ASRs have been proven to enhance safety at hospitals, logistics facilities, manufacturing plants, schools and corporations. ASRs act as highly cost-effective complementary systems to traditional security and law enforcement officials, providing an additional advantage by continuing to offer uninterrupted patrolling capabilities across the country.

The company’s ASRs have assisted in the arrest of suspects involved in crimes ranging from armed robbery to hit-and-runs. Their machine-embedded thermal scanning capability even aided in preventing the breakout of a major fire. You can learn more about the crime fighting wins at www.knightscope.com/crime

The company has achieved several milestones since its creation in 2013, including:

  • Establishing itself in a 15,000-square-foot facility located in Mountain View, California, in the heart of Silicon Valley, where Knightscope designs, engineers and builds its technology (Made in the USA)
  • Operating for more than 1 million hours in the field and securing contracts across five time zones, from Hawaii to Rhode Island
  • Raising over $100 million since inception to build its technology from scratch and generating over $13 million in lifetime revenue, validating both the market opportunity and the technology

Growth Capital & Proposed Nasdaq Listing

With backing from more than 28,000 investors and four major corporations and over $100 million raised since inception, Knightscope is poised to be an industry leader in the future of public safety and security.

On December 1, 2021, Knightscope announced the commencement of an offering of up to $40 million of its Class A common stock, with shares to be listed immediately following closing on the Nasdaq Global Market under the ticker symbol ‘KSCP’. The offering is for up to 4 million shares priced at $10 per share. Learn more at www.knightscope.com/investors

Company Mission – Reimagining Public Safety

Knightscope’s long-term vision has an eye on the greater good. The company’s mission is to make the United States of America the safest nation in the world while supporting the 2+ million law enforcement and security professionals across the country.

Crime has an estimated negative economic impact in excess of $2 trillion annually. As crime is reduced, positive impacts will likely be realized across several aspects of society, including housing, financial markets, insurance, municipal budgets, local business and safety in general.

Knightscope CEO William Santana Li was interviewed by Kevin O’Leary, more commonly known as Shark Tank’s Mr. Wonderful. When asked to explain how the benefits provided by the ASRs outrank a human doing the same job, Li said, “First, just the simple presence of a physical deterrent causes criminal behavior to change. Second, the machines are self-driving cars that patrol all around and recharge themselves. They also generate 90 terabytes of data per year. No human would ever be able to process that. The robots are intended to be eyes and ears for the humans, not a one-to-one replacement.”

The Knightscope solution to reduce crime combines the physical presence of ASRs, sometimes referred to as proprietary Autonomous Data Machines, with real-time onsite data collection and analysis. The ASRs are fitted with eye-level 360° cameras, thermal scanning, public address announcements and various other features that work in tandem with humans to provide law enforcement officers and security guards unprecedented situational awareness.

Those 90 terabytes of data are then formatted in a useable way, so law enforcement can leverage that information and execute their responsibilities more effectively.

Public Safety Innovation

The company’s recurring revenue business model is set up to mimic the recurring societal problem of crime, and it takes into consideration the fact that innovation in the security and public safety industry has been stagnant for decades. Because the traditional practices of the sector have remained unchanged for years, automation has potential to drive substantial cost savings – and significant improvement in capabilities.

Human security guards are one of both the largest expenses and the largest liabilities for companies. Knightscope’s robots are offered at an effective price of $3 to $9 per hour, compared with approximately $85 for an armed off-duty law enforcement officer and $15 to $35 for an unarmed security guard.

This innovation has the potential to drive considerable cost savings. Based on these estimates, manufacturing costs can be recovered as soon as the first year of operation.

Product Offerings

The company has nine patents and a framework of unique intellectual property. Knightscope currently offers a K1 stationary machine, a K3 indoor machine and a K5 outdoor machine. A K7 multi-terrain four-wheel version is in development.

The ASRs autonomously patrol client sites without the need for remote control, providing a visible, force multiplying, physical security presence to help protect assets, monitor changes in the area and deter crime. The data is accessible through the Knightscope Security Operations Center (KSOC), an intuitive, browser-based interface that enables security professionals to review events generated by the ASRs providing effectively ‘mobile smart eyes and ears’. Learn more at www.knightscope.com/ksoc

The ASRs and the related technologies were developed ground up by the company and are Made in the USA.

The Robot Roadshow

Knightscope has created the ultimate hybrid physical and virtual event, bringing its Autonomous Security Robot technologies to cities across the country for interactive and in-person demonstrations.

Each roadshow landing is hosted virtually by a Knightscope expert, and visitors can interact directly with each of the company’s ASRs and see the Knightscope Security Operations Center (KSOC) user interface in action. Learn more at www.knightscope.com/roadshow

Management Team

Chief Executive Officer William Santana Li is a veteran entrepreneur, a former executive at Ford Motor Company and the founder of GreenLeaf, a company that grew to be the world’s second-largest automotive recycler and is now part of LKQ Corporation (NASDAQ: LKQ).

Chief Client Officer Stacy Dean Stephens brings his experience as a former Dallas law enforcement officer, as well as his skills as a seasoned entrepreneur, to assist on the client acquisition side.

Chief Intelligence Officer Mercedes Soria is an award-winning technologist and former Deloitte software engineer.

Chief Design Officer Aaron Lehnhardt brings over two decades of two- and three-dimensional product and industrial design in modeling and VR to the table, on top of his experience as a senior designer at Ford Motor Company.

Chief Financial Officer Mallorie Burke is a seasoned financial executive and strategic advisor for both private and publicly traded technology companies with a successful track record of mergers & acquisitions, corporate growth and exit strategies, including public listings.

General Counsel Peter Weinberg leverages 30 years of diverse corporate counsel experience, spanning from startups to well-established companies, private and public. He has significant experience training personnel at all levels in critical areas to improve corporate compliance and productivity.

Knightscope, Inc. (NASDAQ: KSCP), closed Thursday's trading session at $0.608, off by 5.0297%, on 949,489 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.575101/$4.9997.

Recent News

InMed Pharmaceuticals Inc. (NASDAQ: INM)

The QualityStocks Daily Newsletter would like to spotlight InMed Pharmaceuticals Inc. (NASDAQ: INM).

InMed Pharmaceuticals Inc. (NASDAQ: INM) is a global leader in the manufacturing and clinical development of rare cannabinoids. InMed is a clinical stage company developing cannabinoid-based pharmaceutical drug candidates, as well as manufacturing technologies for pharmaceutical-grade rare cannabinoids.

The company is dedicated to delivering new therapeutic alternatives to treat conditions with high unmet medical needs. The company is also developing a proprietary manufacturing technology to produce pharmaceutical-grade rare cannabinoids in the lab and has recently announced an LOI to acquire a leading rare cannabinoid manufacturer.

Research and Technology

There are more than 100 rare cannabinoids found in only trace amounts in the cannabis plant, together making up less than 1% of the plant’s biomass. InMed is initially focused on the therapeutic benefits of cannabinol (CBN) in diseases with high unmet medical need. Preclinical studies of CBN demonstrated an excellent safety profile and showed CBN has potential for therapeutic benefit over other cannabinoids such as tetrahydrocannabinol (THC) and cannabidiol (CBD).

Evidence suggests there may be great therapeutic potential in rare cannabinoids. Each has a specific chemical structure, and different cannabinoids have been observed to have distinct physiological properties in humans, including therapeutic potential for specific diseases as well as unique safety profiles. CBN is the active pharmaceutical ingredient (API) in InMed’s two lead programs for dermatological and ocular diseases.

InMed’s most advanced compound, INM-755, is a CBN topical cream under clinical development for the treatment of epidermolysis bullosa, a severe genetic skin disorder. To date, INM-755 has been evaluated in two Phase 1 clinical trials in healthy volunteers. InMed has filed Clinical Trial Applications in several countries as part of a global Phase 2 clinical trial of INM-755 (cannabinol) cream in epidermolysis bullosa. Responses from the National Competent Authorities and Ethics Committees are expected throughout the summer of 2021.

InMed is also involved in developing INM-088, an ocular CBN formulation being researched for the treatment of glaucoma, the second leading cause of blindness in the developed world. InMed is currently evaluating several formulations to deliver CBN into the eye to address issues of dosing frequency, side effects and treatment penetration. INM-088 is being designed for topical delivery to the eye. This localized delivery results in very little drug being absorbed or migrating into the bloodstream, thus minimizing potential adverse side effects. INM-088 shows promise to reduce intraocular pressure and provide neuroprotection of the eye.

Manufacturing

The limited availability of rare cannabinoids like CBN makes them economically impractical to extract directly from the plant for pharmaceutical use. InMed is developing IntegraSyn, a cannabinoid synthesis manufacturing system to create rare cannabinoids in the lab that are bioidentical to the compounds derived from the cannabis plant. IntegraSyn uses multiple standard pharmaceutical processes and has achieved a cannabinoid yield of 5 grams per liter, surpassing commercial viability and significantly exceeding currently reported industry yields. InMed is now focusing on manufacturing scale-up to larger batch sizes while continuing process optimization, targeting increased cannabinoid yield and further reducing overall cost of goods.

BayMedica Inc. Acquisition

On June 29, 2021, InMed announced it had entered into a non-binding letter of intent to acquire BayMedica Inc., a private company based in Nevada and California that specializes in the manufacture and commercialization of rare cannabinoids.

As noted in the news release, BayMedica is a revenue-stage biotechnology company leveraging its significant expertise in synthetic biology and pharmaceutical chemistry to develop efficient, scalable and proprietary manufacturing approaches to produce high quality, regulatory-compliant rare cannabinoids for consumer applications. BayMedica is currently commercializing the rare cannabinoid CBC (cannabichromene) as a B2B supplier to distributors and manufacturers marketing products in the health and wellness sector. BayMedica is planning additional rare cannabinoid launches for the coming year.

Pursuant to the indicative terms of the LOI, InMed and BayMedica intend to negotiate and enter into a definitive agreement under which InMed would acquire 100% of BayMedica in exchange for 1.6 million InMed common shares to be issued to BayMedica’s equity and convertible debt holders, with any such issued InMed common shares being subject to a six-month contractual hold period.

Market Outlook

There is a rapidly growing demand for rare cannabinoids. However, their low natural concentration makes traditional harvesting of these compounds cost prohibitive. Biosynthesis allows production of rare cannabinoids in the lab that are bioidentical to compounds found in nature, with significantly higher yields which reduce costs. Biosynthesis can produce pharmaceutical-grade, bioidentical, THC-free compounds at a cost that’s 70 to 90 percent less than wholesale prices of naturally harvested rare cannabinoids.

Cannabinoid-based pharmaceuticals are expected to overtake the market as rare cannabinoids become less expensive and more available. According to Statista, the value of the consumer market for cannabinoid-based pharmaceuticals in the United States is forecast to grow to $25 billion by 2025 and to $50 billion by 2029, with cannabinoid-based pharmaceuticals used to treat health conditions including pain, respiratory conditions, autoimmune conditions and more.

Management Team

Eric A. Adams has been CEO and president of InMed since June 2016. He has more than 25 years of experience in establishing corporate entities, capital formation, global market development, mergers and acquisitions, licensing and corporate governance. He previously served as CEO at enGene Inc. Prior to enGene, he held senior positions in global market development with QLT Inc. (Vancouver), Advanced Tissue Sciences Inc. (La Jolla, CA), Abbott Laboratories (Chicago, IL) and Fresenius AG (Germany).

Bruce S. Colwill is InMed’s CFO. He has more than 25 years of financial leadership experience in public and private companies. Prior to InMed, he served as CFO of General Fusion Inc., a private clean energy company. He was also CFO at Entrée Resources Inc., a mineral exploration company, from 2011 to 2016. He has held CFO roles at Neuromed Pharmaceuticals Ltd., Response Biomedical Corp, Forbes Medi-Tech Inc. and Euronet Worldwide Inc.

Alexandra D.J. Mancini is Senior Vice President, Clinical and Regulatory Affairs at InMed. She has more than 30 years of global biopharmaceutical research and development experience. She has been an executive with numerous biotech companies, including senior vice president of Clinical and Regulatory Affairs at Sirius Genomics; senior vice president of Clinical and Regulatory Affairs at INEX Pharmaceuticals; and vice president of Regulatory Affairs at QLT Inc.

Eric C. Hsu is Senior Vice President, Pre-Clinical Research and Development at InMed. He joined InMed with more than 18 years of scientific leadership experience in the field of gene therapy. He has held various positions within enGene Inc., including vice president of Research and vice president of Scientific Affairs and Operations. He received his Doctorate from the Department of Medical Biophysics at the University of Toronto.

Michael Woudenberg is Vice President, Chemistry, Manufacturing and Controls at InMed. He has more than 20 years of successful drug development, process engineering, GMP manufacturing and leadership experience. He has held positions with 3M, Cardiome Pharma, Arbutus Biopharma and, most recently, was Managing Director of Phyton Biotech LLC.

InMed Pharmaceuticals Inc. (INM), closed Thursday's trading session at $1.17, up 4.4643%, on 107,162 volume. The average volume for the last 3 months is 107,162 and the stock's 52-week low/high is $0.9213/$35.50.

Recent News

FuelPositive Corp. (TSX.V: NHHH) (OTC: NHHHF)

The QualityStocks Daily Newsletter would like to spotlight FuelPositive Corp. (NHHHF).

FuelPositive Corp. (TSX.V: NHHH) (OTC: NHHHF) is a growth stage company focused on licensing, partnership and acquisition opportunities building upon various technological achievements. The company is committed to providing commercially viable and sustainable clean energy solutions, including carbon-free ammonia (NH3), for use across a broad spectrum of industries and applications.

FuelPositive is headquartered in Toronto, Canada.

Hydrogen Economy Problems and FuelPositive’s Carbon-Free Technology

The hydrogen economy is currently facing many challenges. Traditional NH3 manufacturing exists on a massive scale, but centralized facilities result in some of the world’s most concentrated CO2 emissions. In total, an estimated 200 million metric tonnes of NH3 are consumed each year, with greater than 80% utilized by the agricultural sector. NH3 is also being positioned as a viable alternative to fossil fuels.

FuelPositive’s flagship carbon-free ammonia technology provides an innovative solution to these environmental concerns. Developed by Dr. Ibrahim Dincer and his team, the company’s platform allows for the in-situ production of NH3 in an entirely sustainable manner, using only water, air and sustainable electricity.

The production of hydrogen is energy intensive, but it is just one variable hindering the growth of the hydrogen economy. Other hurdles include:

  • Storage – The storage of hydrogen by compression or liquification are both cost prohibitive and unsustainable.
  • Distribution – The distribution network for effective hydrogen deployment has yet to be developed, as the extreme high-pressure distribution requirements to transport hydrogen would result in enormous infrastructure costs.
  • End Use – R&D on the transportation-related end use applications for hydrogen is in its infancy, but almost any vehicle on the road today can be easily converted to run on NH3 at a considerably lower cost per mile traveled when compared to traditional fossil fuels.

A key benefit of FuelPositive’s patent-pending, first-of-its-kind carbon-free NH3 technology is its flexibility. The process allows for small, medium or large-scale production of NH3 on location, minimizing or even eliminating the challenges and volatility associated with storage and transportation to end use. As such, with an appropriately sized FuelPositive system and access to renewable energy, the end use applications for the company’s platform are nearly infinite.

Manufacturing Partnership

On May 19, 2021, FuelPositive announced its selection of National Compressed Air Canada Ltd. (“NCA”) to undertake manufacturing of the company’s Phase 2 hydrogen-ammonia synthesizer commercial prototype systems for carbon-free ammonia production.

In a news release detailing the partnership, FuelPositive CEO Ian Clifford noted, “This critical milestone for FuelPositive will confirm the broad application potential for our technology and is the backbone of our Carbon-Free Hydrogen-NH3 offering. Partnering with the knowledgeable and experienced team at NCA on this commercialization project will bring our development-stage program to life.”

Global Ammonia Market Outlook

The global ammonia market was valued at $52.71 billion in 2017 and is forecast to reach $81.42 billion by 2025, growing at a CAGR of 5.59%, according to data from Fior Markets (https://ibn.fm/1OfOB).

The agricultural industry consumes more than 80% of global NH3. Smaller percentages can be attributed to the waste, water treatment, refrigerants, antiseptic, textile, mining and pharmaceutical industries.

One of the most polluting industries on the planet consists of conventional agribusinesses. These polluters are responsible for more greenhouse emissions per year than transportation. This is where FuelPositive’s technology is expected to be extremely beneficial.

Management Team

Ian Clifford is Director, CEO and Founder of FuelPositive Corp. He has over 25 years of experience in the fields of technology and marketing and has successfully led the company to global brand recognition through its unique energy solutions. Since 2006, Mr. Clifford has raised over $50 million in equity financing for FuelPositive. He also co-founded digIT Interactive, a full-service internet marketing company serving Fortune 500 clients, which he sold at the peak of the market in 2000.

Greg Gooch serves as a Director and President of FuelPositive. His multifaceted career in the electronics and finance industries has positioned him as a key advisor and funding partner to start-ups and new technology companies for over 40 years. Mr. Gooch has been involved with FuelPositive since its early days and has remained a significant supporter and consultant to the company over the years. He has a bachelor’s from McGill University and an MBA from the University of Western Ontario.

Dr. Ibrahim Dincer is a scientific advisor to FuelPositive and is recognized as a pioneer and international leader in the area of sustainable energy technologies. Along with his team, Dr. Dincer invented the modular carbon-free ammonia (NH3) production technology that FuelPositive is commercializing. His area of specialty covers various topics including ammonia, hydrogen energy and fuel cells; renewable energy systems; energy storage systems and applications; carbon capturing technologies, and integrated and hybrid energy systems He is currently managing an exemplary team of researchers in this commercialization project.

Marek Warunkiewicz is the company’s Communications & Branding Specialist. He brings more than 40 years of entrepreneurial expertise to the FuelPositive team, having held marketing, branding, advertising, project management and graphic design positions with various companies. Mr. Warunkiewicz has successfully created business-to-business marketing and advertising campaigns for a diverse group of clients ranging from high-tech to agriculture. He co-founded digIT Interactive and ZENN Motor Company alongside Ian Clifford.

Luna Clifford is the Director of Communications for FuelPositive. She has over 10 years of experience as a business owner and advisor, helping build and operate several successful start-up enterprises while managing complex stakeholder relationships. Ms. Clifford excels in strategic planning and team building, and she has completed extensive studies in the fields of communications and health care.

FuelPositive Corp. (NHHHF), closed Thursday's trading session at $0.09, off by 3.2258%, on 68,777 volume. The average volume for the last 3 months is 68,777 and the stock's 52-week low/high is $0.074/$0.17.

Recent News

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF)

The QualityStocks Daily Newsletter would like to spotlight EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF).

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) is developing Canada’s Renewable Natural Gas Infrastructure Platform, starting on the west coast in British Columbia. The company is combating climate change and helping communities contribute to a sustainable future by acquiring, developing, building, owning and operating a portfolio of renewable natural gas (RNG), waste-to-energy, and related infrastructure projects.

While EverGen is currently focused on British Columbia, its continued growth is expected across other regions of North America. RNG is produced differently than conventional natural gas, without drilling wells. RNG is derived from biogas, which is captured from decomposing organic waste in landfills, food waste, agricultural waste matter and wastewater from treatment facilities. This waste feedstock is supplied to an anaerobic digester which contains bacteria that breaks down organic matter in the absence of oxygen. The resulting biogas is captured and cleaned to create carbon neutral or carbon negative RNG to be used by the existing North American gas pipeline grid. By capturing these emissions and transforming them into RNG, then combusting into CO2, the overall greenhouse gases (GHG) impact is materially less potent than allowing natural decomposition to release methane into the atmosphere. Liquid and solid digestate matter is a byproduct of the RNG production process and is used as fertilizer and in other applications.

EverGen operates three projects in British Columbia. The company was incorporated in 2020 and went public in 2021, with its common shares listed on the TSX Venture Exchange under ticker symbol ‘EVGN’. In February 2022, EverGen’s common shares began trading on the OTCQB Venture Market in the U.S. under ticker symbol ‘EVGIF’. The company is headquartered in Vancouver.

Portfolio Projects

Fraser Valley Biogas is one of three projects in EverGen’s portfolio. Located in Abbotsford, British Columbia, the facility has been digesting manure and off-farm organics since 2011 and was the first agricultural digester in Canada to produce RNG. The RNG generated through this project is part of a FortisBC program to supply renewable gas to homes, businesses and other customers. Fraser Valley Biogas also provides Abbotsford farms with renewable fertilizer via the digestate produced. EverGen acquired Fraser Valley Biogas early in 2021 and is currently enhancing and expanding the facility. These optimization projects resulted in record production during the month of September 2021, supporting the growing demand for RNG in British Columbia. Optimization activities contributed an additional 18% of RNG production for September and a 9% higher year-to-date production compared to the previous year. The facility produces approximately 80,000 gigajoules of RNG, enough to heat more than 1,000 homes for a year.

Net Zero Waste Abbotsford, a wholly owned EverGen subsidiary and portfolio project, is an existing composting and organic processing facility and RNG expansion project. The British Columbia Utilities Commission recently approved a 20-year offtake agreement between the facility and FortisBC, an electricity and gas utility. Under this agreement, FortisBC will purchase up to 173,000 gigajoules of RNG annually for injection into its natural gas system upon completion of an anaerobic digester project at Net Zero Waste Abbotsford. Once construction is complete, this project is expected to produce enough energy to meet the needs of more than 1,900 homes.

Sea to Sky Soils, a wholly owned EverGen subsidiary and portfolio project, is an existing composting and organic processing facility and potential future RNG expansion project which has been operating near Pemberton, British Columbia, on Lil’wat Nation land since 2012. The Lil’wat Nation is a key partner and supporter of the facility, which has employed a majority of its staff from the First Nation since inception. The Sea to Sky Soils facility processed approximately 160 percent of its forecast tonnage in the second half of 2021. In total, Sea to Sky Soils processed approximately 36,000 tons of organic waste in 2021. The facility is working with the Ministry of Environment to expand its operational capacity in 2022. EverGen has partnered with local municipalities – including Metro Vancouver and the municipality of Pemberton – for the delivery of additional organic waste to the facility. The facility is an important part of EverGen’s RNG infrastructure platform and serves as a source of valuable feedstock to support the company’s existing and future operations.

Market Outlook

A report from Global Market Insights states that the biogas market is projected to see significant growth over the next few years, driven by a shifting preference to utilize biogas to reduce emission levels from traditional fuels. Escalating RNG usage by gas utilities as a sustainable and low carbon alternative to supply heat and electricity in industries and buildings will further stimulate growth. RNG is increasingly deployed across the transport sector, especially for heavy vehicles and vessels, to abate GHG emissions.

Many North American gas utilities have set RNG targets of 5% to 15% of production by volume in 2030, compared to less than 1% by volume in 2020. FortisBC has a goal of including 15% RNG in its gas supply by 2030. EverGen believes this presents a potential C$16 billion+ opportunity for RNG producers.

Management Team

Chase Edgelow is co-founder and CEO at EverGen. He has over 15 years of specialized private investment, finance, and technical expertise in the energy and infrastructure sectors. His background is as a Facilities Engineer with Petro-Canada, independently managing energy infrastructure capital projects located in western Canada. He holds a Professional Engineer designation from the province of Alberta.

Mischa Zajtmann is co-founder and President at Evergen. He has 15 years of experience providing consulting and management for Canadian and American companies in the natural resources and energy space. He is a corporate securities lawyer who began his career at Blake, Cassels & Graydon LLP. His J.D. is from the University of Saskatchewan Law School. He’s a member of the British Columbia Bar.

Sean Mezei is COO at EverGen. He has 20 years of experience in the RNG industry, having served previously as the president of Greenlane Biogas and as a senior manager at QuestAir, and founder and president of Dekany Consulting. He was a co-chairman of the American Biogas Council’s RNG working group for six years. He has been a Registered Professional Engineer in the province of British Columbia since 1994.

Natasha Monk is CFO at EverGen. She is a CPA with 12 years accounting, financial reporting, and tax experience in public practice and industry. She is currently a partner at Affirm LLP, where she advises and consults to a wide variety of companies in multiple industries across public and private sectors. Prior to joining EverGen, she worked at KPMG. She graduated from the University of Calgary.

EverGen Infrastructure Corp. (OTCQX: EVGIF), closed Thursday's trading session at $2.59, even for the day. The average volume for the last 3 months is 1 and the stock's 52-week low/high is $1.365/$3.20.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.